Michele L. Martinho, M.D.; Decision and Order, 24012-24020 [2021-09464]
Download as PDF
24012
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. MV3148257 issued
to Melanie Baker, N.P., and deny any
pending applications for renewal or
modification of that registration. This
Order is effective June 4, 2021.
D. Christopher Evans,
Acting Administrator.
[FR Doc. 2021–09463 Filed 5–4–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Michele L. Martinho, M.D.; Decision
and Order
On December 4, 2019, the Drug
Enforcement Administration
(hereinafter, DEA or Government)
Administrative Law Judge Mark M.
Dowd (hereinafter, ALJ), issued a
Recommended Rulings, Findings of
Fact, Conclusions of Law, and Decision
of the Administrative Law Judge
(hereinafter, RD) on the action to revoke
the DEA Certificate of Registration
Number BM9434440 of Michele L.
Martinho, M.D. The ALJ transmitted the
record to me on January 7, 2020, and
asserted that no exceptions were filed
by either party. ALJ Transmittal Letter,
at 1. Having reviewed and considered
the entire administrative record before
me, I adopt the ALJ’s RD with minor
modifications, where noted herein.*
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby dismiss the Order to
Show Cause issued to Michele L.
Martinho, M.D. This Order is effective
immediately.
D. Christopher Evans,
Acting Administrator.
Paul E. Soeffing, Esq., for the
Government
Douglas M. Nadjari, Esq. and David
Durso, Esq., for the Respondent
*A I have made minor, nonsubstantive,
grammatical changes to the RD. Where I have made
any substantive changes, omitted language for
brevity or relevance, or where I have added to or
modified the ALJ’s opinion, I have bracketed the
modified language and explained the edit in a
footnote marked with an asterisk and a letter in
alphabetical order.
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
Recommended Rulings, Findings of
Fact, Conclusions of Law, and Decision
of the Administrative Law Judge
The Assistant Administrator,
Diversion Control Division, Drug
Enforcement Administration (DEA),
issued an Order to Show Cause (OSC),1
dated February 26, 2019, seeking to
revoke the Respondent’s Certificate of
Registration (COR), number
BM9434440, pursuant to 21 U.S.C.
824(a)(5), and deny any applications for
renewal or modification of such
registration and any applications for any
other DEA registrations pursuant to 21
U.S.C. 824(a)(5), because the
Respondent has been excluded from
participation in a program pursuant to
section 1320a–7(a) of Title 42. The
Respondent requested a hearing on
March 13, 2019,2 and prehearing
proceedings were initiated.3 A hearing
was conducted in this matter on October
3, 2019, at the DEA Hearing Facility in
Arlington, Virginia.
The issue ultimately to be adjudicated
by the Acting Administrator, with the
assistance of this recommended
decision, is whether the record as a
whole establishes by a preponderance of
the evidence that the Respondent’s
subject registration with the DEA should
be revoked pursuant to 21 U.S.C.
824(a)(5).
After carefully considering the
testimony elicited at the hearing, the
admitted exhibits, the arguments of
counsel, and the record as a whole, I
have set forth my recommended
findings of fact and conclusions of law
below.
The Allegations
In the OSC, the Government contends
that the DEA should revoke the
Respondent’s DEA COR because she has
been excluded from participation in a
program pursuant to section 1320a–7(a)
of Title 42.
Specifically, the Government alleges
the following:
1. The Respondent is registered with
the DEA as a practitioner in Schedules
II through V under DEA COR
BM9434440. The Respondent’s COR
expires by its terms on January 31, 2020.
2. On June 14, 2017, the Respondent
was found guilty in the United States
District Court for the District of New
Jersey of ‘‘Transporting in Aid of-Travel
Act-Accepting Bribes in Violation of the
Travel Act.’’ Judgment was entered in
U.S. v. Michele Martinho, No. 2:14–CR–
00271–SRC–1 (D.N.J. filed June 14,
2017).
1 ALJ
Ex. 1.
Ex. 2.
3 ALJ Ex. 3.
2 ALJ
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
3. Based on the Respondent’s
conviction, the U.S. Department of
Health and
Human Services, Office of Inspector
General (‘‘HHS/OIG’’), by letter dated
July 31, 2018, mandatorily excluded the
Respondent from participation in
Medicare, Medicaid, and all federal
health care programs for a minimum
period of five years pursuant to 42
U.S.C. 1320a–7(a), effective August 20,
2018. Notwithstanding the fact that the
underlying conduct for which the
Respondent was convicted had no
nexus to controlled substances,
mandatory exclusion from Medicare,
Medicaid, and all federal health care
programs by HHS/OIG warrants
revocation of the Respondent’s
registration pursuant to 21 U.S.C.
824(a)(5).
The Hearing
Government’s Opening Statement
In the Government’s Opening
Statement, the Government indicated
that revocation is sought for the
Respondent’s COR involving Schedules
II through V, pursuant to 21 U.S.C.
824(a)(5). Tr. 10. The facts in this matter
are undisputed and have been
stipulated to by the parties. Id. The
Respondent was found guilty in U.S.
District Court of transporting in aid of
the Travel Act and accepting bribes in
violation of the Travel Act. Id. The
following year, HHS/OIG mandatorily
excluded the Respondent from
participation in Medicare, Medicaid,
and all federal health care programs. Id.
at 10–11. Pursuant to 42 U.S.C. 1320a–
7(a), the Respondent’s exclusion
remains in effect, which is the basis
upon which the DEA seeks to revoke the
Respondent’s COR. Id. at 11.
Respondent’s Opening Statement
The Respondent asserted in her
opening statement that this matter is not
about controlled substances, and it has
nothing to do with the issuance of
prescriptions or record keeping for
controlled substances. Id. at 11. The
Respondent admitted that the
Government is correct that she accepted
cash payments in exchange for referring
blood work to a particular lab, that she
pleaded guilty to a single count
violation of the Travel Act, and that she
has been excluded by HHS/OIG from
participation in Medicare, Medicaid,
and all federal health care programs. Id.
at 11–12. The Respondent maintained
that the evidence will show that the she
can be entrusted to maintain and
properly use her DEA COR. Id. at 12.
Revocation in this matter is not
mandatory. Id. at 12. The Respondent
E:\FR\FM\05MYN1.SGM
05MYN1
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
asserted that she has accepted
responsibility and has demonstrated
that she will not engage in misconduct
again. Id. at 12.
Dr. Martinho completed courses of
study in medical ethics before her
criminal proceedings began. Id. at 12–
13. She also began to lecture other
doctors and medical students about her
experiences to help prevent them from
making the same choices she did. Id. at
13–14. She has given over 60 lectures
during her own time and at her own
expense. Id. at 14. During her
sentencing hearing at the U.S. District
Court, the presiding judge said that ‘‘he
felt that her talks had a greater deterrent
impact than anything that the court or
the U.S. Attorney could have done to
prevent other people—to deter other
people from engaging in this kind of
conduct.’’ Id. at 14. Dr. Martinho’s
efforts have been featured in the
Washington Post, the Wall Street
Journal, and on NPR. Id. at 14. The
Respondent submitted that the evidence
will show that she can be entrusted to
maintain her DEA COR. Id. at 15. She
has used her COR properly throughout
her life. Id. The Respondent argued that
the evidence will demonstrate that the
Government’s application to revoke the
Respondent’s COR should be denied. Id.
Iraqi Police Department. Id. at 20. He
has a Bachelor’s Degree from City
College of New York. Id. at 21. The DI
indicated that he was assigned this
matter by his group supervisor. Id. at 22.
The DI identified the criminal judgment
in the criminal case of U.S. v. Michele
Martinho from the U.S. District Court in
Newark, New Jersey. Id. at 23; GX 2. He
obtained a copy of the judgment via
email from the District Court. Tr. 23.
Next, he identified a letter from the
HHS/OIG regarding the exclusion of the
Respondent from all federal health care
programs. Id. at 24; GX 3. He obtained
it via email from the OIG. Tr. 25.
The DI identified a screenshot from
the OIG’s website that demonstrated
that the Respondent was still excluded
from all federal health care programs as
of the morning of October 3, 2019, the
date of the hearing in this matter. Tr.
25–26; GX 4. He obtained this document
by going to the OIG’s website and taking
a screenshot of the Respondent’s
information. Tr. 26. He verified the
information on the morning of the
hearing by going to the OIG’s website,
entering the Respondent’s name, and
confirmed that she was still excluded.
Id. at 27.
Government’s Case in Chief
Before presenting witnesses, the
Government offered the sworn and
notarized COR history for the
Respondent, which was admitted
without objection.4 See GX 1.5 The
Government otherwise presented its
case in chief through the testimony of a
single witness. The Government
presented the testimony of a Diversion
Investigator (hereinafter, the DI).6
Dr. Michele Martinho, M.D.
The Respondent currently lives in
New York, where she has been licensed
to practice medicine since 2005. Id. at
29. The Respondent is forty-five years
old and has two children for whom the
Respondent is the primary caretaker. Id.
at 45. She is first generation American,
with both of her parents being
Portuguese immigrants. Id. She went to
Catholic school from grades K–12 and
received her undergraduate degree in
psychology from New York University.
She went on to attend Ross University
for medical school for two years in the
Caribbean and returned to the United
States for her clinical rotations for the
last two years, from which she
graduated in 2002. Id. at 47. She
completed her residency at Mount Sinai
Elmhurst Hospital with a focus in
internal medicine, which lasted another
three years. Id. After completing her
residency, she worked at a satellite
clinic for the hospital for almost three
years in preparation for private practice.
Id. at 48. She then went into private
practice and eventually purchased the
practice. Id. at 48–49. Her practice is
located in the Lower East Side of
Manhattan. Id. at 49. It is surrounded by
a significant amount of government
public housing whose tenants make up
a large portion of her practice. Id. Over
the years, as the population of
The DI
The DI is a Diversion Investigator for
the DEA and has been employed by the
DEA for two years, currently assigned to
the New York Division. Tr. 20. He
previously served with the New York
City Police Department for 23 years,
retiring as a Detective Sergeant. Id. at
20. He also served in the U.S. Army
Reserves, retiring as a Lieutenant
Colonel. Id. at 20. He additionally
served for four years in the United
Nations International Police Task Force
in Kosovo, including one year as a
Regional Security Officer in Liberia and
six months in Iraq working with the
4 The Respondent noted that all of the
Government’s evidence had been stipulated to and
that there were no objections to any of the
Government’s exhibits. Tr. 18.
5 GX—Government Exhibit
6 The DI was called to sponsor the Government’s
exhibits. Tr. 18–19.
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
Respondent’s Case in Chief
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
24013
Manhattan has changed, her patients
have transitioned to younger patients.
Id.
The Respondent explained the genesis
of her involvement in the criminal
activity for which she was convicted. Id.
at 50. Prior to her purchasing the
practice, the Respondent was
introduced by a lab testing
representative to K.K., a sales
representative for Biodiagnostic Testing
Laboratories (BIL), a blood testing lab.
Id. at 29–30, 50. BIL was located in New
Jersey, but was looking to gain business
in New York. Id. at 50–51. The
unnamed lab testing representative
introduced the Respondent to the owner
of BIL. The three of them had dinner
together where they offered the
Respondent what amounted to a referral
fee for referring bloodwork to their lab,
to which the Respondent conceded that
such financial arrangement does not
exist in the medical field. Id. at 51.
She was paid every month by the
laboratory’s representative with an
envelope of cash. Id. Over the course of
two and a half years, she received
$155,000. Id. at 51–52. When asked
about the process that resulted in the
bribes, the Respondent explained that
patients would come into her office and
she would conduct a blood draw on the
patients who needed it, including new
patients. Id. at 80. She decided which
lab would get the blood depending on
which insurance company the patient
had. Id. She testified that BTL lied to
her and said they took all insurances.
When she found out that they did not
take certain insurances, she stopped
sending certain patients’ blood work to
that lab, because she did not want
patients getting a bill. Id. She said that
either she or a member of her staff
would conduct the draw and a note
would be placed in the patient’s file
designating the blood testing lab. Id. at
80–81. She had billing software set up
with the lab so she could order the lab
tests online. Id. at 81.
The Respondent stopped taking the
cash payments once the laboratory
owner and a few laboratory
representatives were arrested on April
13, 2013, for bribery. Id. at 53. The
Respondent explained that while she
did not know that the referral fee was
illegal, she did know that what she was
doing in taking the cash was wrong and
admitted ‘‘[t]hat I own 100 percent.’’ Id.
at 53–54. The Respondent admitted that
she knew it was wrong to accept the
payments at the time she accepted them.
Id. at 52. Although the Respondent did
not realize that the referral fees would
be considered bribes under the law, she
admitted that she accepted the money
and now realizes they constituted illegal
E:\FR\FM\05MYN1.SGM
05MYN1
24014
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
bribes. Id. at 51. The Respondent
understood what she did was also
wrong from a moral standpoint. Id. at
56. She claimed that she understood
that she violated her fiduciary
responsibility to her patients, and that
she had been questioned by patients at
her practice when they learned about
the allegations. Id. She found that when
she was questioned by patients as to the
medical necessity of the blood draws
and whether she had only done it for
the money, it was a ‘‘big moment’’ for
her. Id. at 56–57, 58. She explained that
a moderator at one of the health care
courses she has attended explained this
violation of patient trust aspect to her,
and it has affected how she has
attempted to remediate herself. Id. at 57.
She again claimed full responsibility for
her actions and did not place blame on
the laboratory or the laboratory
representative. Id. When asked
pointedly by the Government whether
she accepted responsibility for the acts
that led to her criminal conviction, the
Respondent answered, ‘‘[o]ne hundred
percent, yes.’’ Id. at 74. She further
confirmed that she considers those
criminal actions to be serious violations
of the law and that she is remorseful. Id.
at 74–75. Apart from copays, she had
not ever taken cash payments before
that time, and has not since. Id. at 52.
The Respondent asserted that while
she now understands that ignorance of
the law is no excuse, at the time, she did
not fully understand what bribery
meant. Id. at 54–55. The Respondent
ultimately amended her tax returns and
paid the taxes on the cash payments. As
part of her criminal sentence, the
Respondent paid back the $155,000. Id.
at 52, 55–56. She stated that she never
conducted medically unnecessary blood
draws. Id. at 55. As developed in her
criminal case, there was never any
allegation by the Government that the
blood testing lacked medical necessity.
Id. at 58.
The Government’s investigation into
BTL resulted in the prosecution and
conviction of a large number of
physicians, including the Respondent.
Id. at 30. The Respondent cooperated
with the Government in the
investigation and prosecution involving
BTL. The Respondent ultimately pled
guilty to violating the federal Travel Act
by accepting bribes for sending some of
her blood work to BTL. Id. at 30. The
Respondent continued to lawfully send
blood work to two other laboratories,
including Quest Diagnostics and Bio
Reference. Id. at 30–31.
The Respondent testified that her
federal criminal case did not involve
controlled substances, prescriptions for
controlled substances, or record keeping
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
for controlled substances. Id. at 31. She
has never before been disciplined or
sanctioned for her prescribing methods
with respect to controlled substances or
her record keeping practices. Id. The
Respondent discussed each of her
proposed documentary evidentiary
exhibits.7 Id. at 31–32. The Respondent
identified a presentencing
memorandum given to the District Court
judge before her sentencing in 2017. Id.
at 32; RX 1.8 The Respondent identified
a flyer for Boston Medical Center, which
advertised an event, in which she was
the keynote speaker for their Ethics and
Compliance Week in 2017. Tr. 33; RX 2.
The Respondent indicated that this was
an example of the type of lectures she
has given and continues to give, as
discussed in her opening statement. The
flyer included a picture, a description of
the crime of conviction and the purpose
of the lecture. Id. at 33.
The Respondent offered a letter from
Dr. B.F., who is an orthopedic surgeon
at MD Anderson. Tr. 34; RX 3. Dr. B.F.
invited the Respondent to speak with
his orthopedic fellows to tell her story
and hopefully deter them from engaging
in similar behavior for which she had
been convicted. Tr. 34. It was submitted
to the District Court in conjunction with
the presentencing memorandum. Id.; see
RX 1. The Respondent offered a letter
from Dr. J.E., a professor of philosophy
at Marin University. Tr. 35–36; RX 4.
The Respondent contacted him and
offered to give her presentation to his
medical students, which he accepted.
Tr. 36. It was also submitted to the
District Court in conjunction with the
presentencing memorandum. Id.
The Respondent offered a letter from
J.W., an ethics professor from Ohio
University. Tr. 36–37; RX 5. J.W.
arranged for the Respondent to provide
a radio presentation on NPR regarding
her crime. Tr. 37. The Respondent
offered a newspaper article from the
Washington Post, featuring the
Respondent and her presentation at
Georgetown University. Tr. 38; RX 6.
The Respondent offered certificates for
completion of programs in health care
ethics. Tr. 39–41; RX 7, 8. The
Respondent offered the transcript of her
sentencing hearing before the U.S.
District Court conducted on June 14,
2017. Tr. 41; RX 9.
Finally, the Respondent offered a
consent agreement between her and the
New York State Department of Health
State Board for Professional Medical
Conduct. Tr. 42; RX 10. The Respondent
explained that after her sentencing in
7 The Government did not object to any of the
Respondent’s proposed documentary evidence.
8 RX—Respondent’s Exhibit
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
the District Court, a pre-hearing was
conducted with the New York State
Department of Health, Office of
Professional and Medical Conduct, and
based upon her efforts at remediation,
the Respondent was allowed to continue
practicing medicine with no
interruptions or restrictions placed on
her state license. Tr. 44–45.
Following completion of her ethical
course of study at Creighton University,
the Respondent discovered that the
prosecutor on her criminal case was
going to law schools to discuss health
care fraud. She offered to go with the
prosecutor and tell her side of the story
to the students. Tr. 60–61. While the
prosecutor declined her invitation, she
began to research medical schools, law
schools, ethics societies, and medical
societies to share her story to whomever
would listen and would benefit from her
presentation. Id. at 61–62. She sent out
a cold email and offered to pay her own
travel and expenses for the opportunity
to share her story, which has cost
approximately $20,000, in addition to
taking her away from her current
practice. Id. at 62, 68, 74. As of the date
of the instant hearing, the Respondent
indicated that she had completed sixtynine of these speaking engagements and
continues to do them. Id. at 62–63.
The Respondent discovered
‘‘restorative justice’’ during one of her
medical ethics courses and began to
focus on that. Id. at 63–64. She found it
was not just about being sorry for your
conduct, but how she could do better
and correct her mistake. Id. at 64. She
explained that she understood her crime
had affected her patients, other
physicians, and the community. Id. at
64–65. The Respondent indicated that
medical school does not adequately
prepare students for these real-life
issues and that she wanted to share her
experience as an example. Id. at 65. The
Respondent reported that J.W. (see RX
5) was an educator of health care ethics,
and that J.W. told the Respondent that
she was changing her curriculum to
include scenarios such as the
Respondent’s experience. Id. The
Respondent further advised that at one
of the schools she spoke, New York
Medical College, they established a
medical legal course for their law
students and medical students to
discuss situations similar to the
Respondent’s in order to better prepare
their students. Id. at 66.
The Respondent opened her
presentation by giving her name,
explaining that she is an internal
medicine physician from New York, and
that she was convicted of a crime in
2014, referring to herself as a felon. Id.
at 67. She testified that she always refers
E:\FR\FM\05MYN1.SGM
05MYN1
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
to herself as a felon as that is part of her
story. Id. The Respondent noted
statements made by the prosecutor, the
sentencing judge, and probation
department during her sentencing
hearing in support of the Respondent
and her remedial actions taken since
pleading guilty. Tr. 68–71; RX 9, pp. 9,
13–14.
The Respondent was questioned
regarding whether the underlying
criminal conduct was ‘‘aberrational’’
and how she can be entrusted to
maintain her DEA COR. Id. at 71–72.
The Respondent testified that for the
past six years, she has been able to reach
thousands of medical students and
physicians. Id. at 72. She said that some
of her presentations at universities have
been recorded and are required to be
watched by students, so she knows she
is making an impact on medicine in this
way. Id. She stated that she wants to
continue in her profession because it is
what she has wanted for her entire life.
Id.
When questioned, she indicated that
while she had been ordered to complete
thirty lectures by the sentencing judge,
she had already completed twenty-six
speaking engagements by the date of the
sentencing hearing. Id. at 73. She was
ordered to complete thirty presentations
within two years of sentencing, which
she completed in only six months. Id.
She further indicated that she has no
plans to stop doing her speaking
engagements, even though her probation
term ended on June 14, 2019. Id. at 73–
77, 90.
She further offered her cooperation to
a number of government agencies as
part of her remedial efforts. Tr. 85–87;
RX 1, p. 463. She testified that she
brought information concerning other
potential criminal activity to
approximately seven other state and
federal law enforcement agencies across
the federal government and two states,
for which she received a 5K reduction
letter for those efforts.9 Tr. 87. The
Respondent scored a level 19 of the
sentencing guidelines, which would
normally carry a punishment of thirty to
thirty-seven months in prison. Id. at 88.
The prosecutors in the criminal case
filed a 5K1 recommendation letter,
which recommended that she be
sentenced within a guideline level
which would make her probation
eligible. Id. at 88–89. She stated that
9 A ‘‘5K reduction’’ refers to USSG § 5Kl.l—
Substantial Assistance to Authorities. Upon motion
of the Government stating that the defendant has
provided substantial assistance in the investigation
or prosecution of another person who has
committed an offense, the court may depart from
the guidelines.
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
every other physician involved in the
matter went to prison. Id. at 89.
The Respondent indicated that she
plans to reapply to participate in
Medicare and Medicaid when her
exclusion is over. Id. at 77. She
explained that she had been excluded
from Medicare, Medicaid, and the State
of New York’s Medicaid program, which
she appealed and had rescinded. Id. at
77–78. She stated that she had been
excluded from the state program even
though she hadn’t been participating in
the program following her residency. Id.
at 78–79.
When I asked the Respondent if she
had ever before taken the position that
she did not commit the bribery, she
responded, no, she had never taken that
position, nor the position that bribery
was not a serious offense warranting
punishment. Id. at 83. She testified that
after she had found out she had
committed a crime, she had her office
manager pick a random selection of
patients to determine whether the rate
of ordering bloodwork had increased at
all based on the bribes. Id. at 84. The
office manager picked one-hundred
random patients established before the
Respondent purchased the practice,
one-hundred new patients before using
BTL, and one-hundred new patients
after starting to use BTL. Id. The office
manager found that there was
essentially no difference in the rate or
frequency of ordering or what types of
tests were ordered. Id. at 84.
I asked why she believed that the
Acting Administrator should trust her
with her COR. Id. at 121. The
Respondent asserted credibly that her
efforts over the past six years is
evidence of her contrition and trying to
‘‘pay it forward to the next generation of
physicians.’’ Id. at 121–22. She cannot
imagine repeating any part of her life
from the past six years due to fear of
going to jail, not being able to support
her children, or not being able to take
care of them. Id. at 122. She expressed
that she would ‘‘never do anything to
compromise [her] license ever again.’’
Id.
P.R., J.D., M.S.W., M.Bioethics
P.R. is currently a professor at Temple
University’s Lewis Katz School of
Medicine and the Center for Bioethics
Urban Health and Policy. Id. at 94. She
also serves as the Assistant Director of
the Master’s program in Urban
Bioethics. Id. She received her
bachelor’s degree in political science, a
master’s degree in social work from the
University of Pennsylvania, School of
Social Policy and Practice, and a law
degree from Temple University’s law
school. Id. at 93. She has previously
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
24015
taught at Drexel University, Simmons
College, and previously worked as a
geriatric social worker for
approximately five years. Id. at 94.
P.R. met the Respondent through an
email the Respondent sent to the Center
for Urban Bioethics approximately one
year before P.R. started at the Center. Id.
at 95. After a review of the Respondent’s
email, P.R. contacted the Respondent to
hear more about her experiences and to
determine if it would be appropriate for
the Respondent to come to the
University and speak to the students. Id.
at 95. P.R. found that the Respondent’s
experience ‘‘would be a good fit for their
program’’ and she invited the
Respondent to come and talk to her
class of physician assistants in the
summer of 2017. Id. at 96. Since that
time, the Respondent has spoken to
several classes at Temple University.
P.R. also invited her to speak to her
students at Simmons College, including
social work students, and undergraduate
health care administration students at
Drexel University. Id. at 97.
P.R. described the Respondent’s
lecture and her presentation to the
students. Id. at 97–98. She found the
Respondent’s story very ‘‘honest, raw,
and compelling.’’ Id. at 97. The
Respondent did not minimize her
actions or try to make excuses, but
explained what she had done and how
it had happened. Id. at 98–99. The
Respondent explained that apart from
the medical knowledge required of
health care professionals, it is also
important to ‘‘have a sense of how to
run a business’’ and other necessary
considerations before entering the
health care field. Id. at 98.
P.R. expressed that the Respondent
showed contrition during her
presentation. Id. at 100. She also
expressed that the Respondent
‘‘[a]bsolutely’’ accepted responsibility
for her actions. Id.. She found that the
Respondent’s reputation among the
students was one of respect for being
candid about her story, and that the
students found her talk to be very
relevant to their education, and what it
looks like to be confronted with ethical
decisions in the field. Id. at 100–01.
I asked P.R. if the Respondent
appeared sincere in her presentations to
students. Id. at 101. P.R. indicated that
the Respondent ‘‘could not have been
more sincere.’’ Id. P.R. expressed that it
was clear from the Respondent’s
demeanor that she was being truthful
and honest about her story. Id. at 102.
There was no doubt in P.R.’s mind that
she was absolutely sincere in her
presentations. Id. The Respondent gave
live presentations twice at the Center for
Urban Bioethics. She gave four live
E:\FR\FM\05MYN1.SGM
05MYN1
24016
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
presentations for P.R. in total. Id. at
102–03. She found that the
Respondent’s talk was beneficial to the
students as it demonstrated what a realworld ethical dilemma looks like and
not only showed the consequences of
making a bad decision, but also what a
person can do to correct their mistake.
Id. at 103–04. P.R. explained what she
perceived to be a lack of ethical training
in medical school, and found that the
Respondent’s presentations provided a
bridge between this gap. Id. at 104–06.
P.R. stated that the Respondent is
‘‘exactly the type of doctor I would want
to have’’ and that ‘‘we’re wanting our
students to be.’’ Id. at 105.
Dr. J.G., M.D.
Dr. J.G. received her undergraduate
degree from Stony Brook, her master’s
degree from Brooklyn College, and
finally her medical degree at Ross
University. Id. at 108. She completed
her residency in obstetrics and
gynecology at George Washington
University. Tr. Id. Afterwards, she began
working at Columbia University,
Columbia Presbyterian in the Allen
Pavilion for two years. Id. at 109. She
then joined Mt. Sinai Hospital and
Icahn School of Medicine as an
Assistant Professor in obstetrics,
gynecology, reproduction, endocrine
and fertility, and minimally invasive
surgery, where she worked until the end
of 2013. Id. She went on to BronxCare
Health System as an Assistant Professor
in obstetrics and gynecology. Id. After
her time in academia, she moved into
private practice at Maiden Lane Medical
before presently moving to join the
Respondent at the Respondent’s practice
as a gynecologist. Id. at 110.
Dr. J.G. met the Respondent during
medical school and they became close
friends. Id. They have been friends for
about 21 years. Id. at 118. She has
referred patients to the Respondent and
the Respondent has referred patients to
her. Id. at 111. Dr. J.G. opined that the
Respondent provides excellent care to
her patients, is a very thorough and
excellent clinician, and that she trusts
the Respondent with their care. Id. at
111. Dr. J.G. has found that her patients
greatly enjoy being treated by the
Respondent. Id. at 111–12. Despite
being aware of the Respondent’s
conviction and the circumstances
surrounding it, Dr. J.G. continues to
refer patients to the Respondent. Id. at
112. From her observations, she found
that one particular patient was
‘‘remarkably healthier’’ after being
treated by the Respondent. Id.
Dr. J.G. says that she has personally
observed that the Respondent has
accepted responsibility for the conduct
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
which led to her conviction. Id. at 113–
14. She has observed the Respondent
not only show remorse for her conduct
and to try and better understand what
she did wrong, but that the Respondent
has gone out to share her experiences
with medical students and residents. Id.
at 114–15. Dr. J.G. reiterated that ethics
education is lacking in medical school,
and she found the Respondent’s lectures
to be ‘‘beyond remarkable.’’ Id. at 115.
Based upon her professional and
personal interactions with the
Respondent, Dr. J.G. has found that the
Respondent is an excellent judge of
medical treatment. Id. at 115. The
Respondent is a thorough clinician and
takes her time with each patient to
provide thorough treatment. Id. at 115–
16. Although Dr. J.G. is preparing to join
the Respondent’s practice, she does not
currently have a financial relationship
with the Respondent. Tr. 116. When she
refers patients to the Respondent, there
is no referral fee or fee sharing and Dr.
J.G. noted that that is illegal within the
profession. Id. at 117. When Dr. J.G.
enters into a practice arrangement with
the Respondent, she expects they will
share expenses equally for staff, rent
and utilities. Id. at 116–17.
Dr. J.G. holds a DEA Certificate of
Registration and is familiar with the
responsibilities of being a registration
holder. Id. at 117–18. She believes that
the Respondent possesses all of the
necessary requirements, ethics,
judgment, and aptitude to hold a DEA
COR. Id. at 118.
The Facts
Stipulations of Fact
The Government and the Respondent
have agreed to five stipulations, which
I recommend be accepted as fact in
these proceedings:
1. Respondent is registered with the
DEA as a practitioner in Schedules II
through V under DEA Certificate of
Registration BM9434440 with a
registered address of 308A East 15
Street, New York, NY 10003, and a
mailing address of 20 River Terrace,
Apt. 23E, New York, NY 10282.
Respondent’s registration expired by its
terms on January 31, 2020.
2. On June 14, 2017, Respondent was
found guilty in the United States
District Court for the District of New
Jersey of ‘‘Transporting in Aid of Travel
Act-Accepting Bribes in Violation of the
Travel Act,’’ in violation of 18 U.S.C.
1952(a)(3) and 18 U.S.C. 2. Judgment
was entered against Respondent in U.S.
v. Michele Martinho, No. 2:14–CR–
00271–SRC–1 (D.N.J. filed June 14,
2017).
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
3. Based on Respondent’s conviction,
the U.S. Department of Health and
Human Services, Office of Inspector
General (‘‘HHS/OIG’’), by letter dated
July 31, 2018, mandatorily excluded
Respondent from participation in
Medicare, Medicaid and all federal
health care programs for the minimum
period of five years pursuant to 42
U.S.C. 1320a–7(a), effective August 20,
2018.
4. Reinstatement of eligibility to
participate in Medicare, Medicaid and
all federal health care programs after
exclusion by HHS/OIG is not automatic.
5. Respondent is currently excluded
from participation in Medicare,
Medicaid and all federal health care
programs.
Findings of Fact
The factual findings (FoF) below are
based on a preponderance of the
evidence, including the detailed,
credible, and competent testimony of
the aforementioned witnesses, the
exhibits entered into evidence, and the
record before me.
1. The Respondent currently holds
DEA COR BM9434440 in Schedules II
through V with a registered address of
308A East 15 Street, New York, NY
10003, and a mailing address of 20 River
Terrace, Apt. 23E, New York, NY 10282.
The Respondent’s COR expires by its
terms on January 31, 2020. ALJ Ex. 1, 9.
2. The Respondent received her
undergraduate degree in psychology
from New York University. Id. at 47.
3. The Respondent attended Ross
University for medical school and
returned to the United States for her
clinical rotations, from which she
graduated in 2002. Id. at 47.
4. The Respondent completed her
residency at Mount Sinai Elmhurst
Hospital with a focus in internal
medicine. Id. at 47.
5. The Respondent worked at a
satellite clinic for the hospital for almost
three years after her residency. Id. at 48.
6. The Respondent went into private
practice and eventually purchased the
practice, which is an internal medicine
practice on the Lower East Side of
Manhattan. Id. at 48–49.
7. The Respondent has been licensed
to practice medicine in the state of New
York since 2005. Id. at 29; RX 10.
Respondent’s Criminal Act, Conviction,
and Exclusion
1. The Respondent pled guilty to
‘‘[v]iolating the federal Travel Act for
accepting bribes for sending [her
patients’] blood work to a laboratory.’’
Tr. 30. She was sentenced to probation
for a period of two years, of which the
E:\FR\FM\05MYN1.SGM
05MYN1
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
first twelve months were served in
home confinement. RX 9.
2. The Respondent has never been
disciplined or sanctioned concerning
her prescribing of controlled substances.
Tr. 30.
3. The Respondent’s conviction did
not involve any controlled substances.
Id. at 31.
4. After her sentencing in her criminal
case, the New York State Department of
Health, Office of Professional and
Medical Conduct, allowed the
Respondent ‘‘to continue to practice
medicine with no interruption and no
restriction.’’ Id. at 44–45; RX 10.
5. The Respondent accepted a referral
fee or bribe to send her patients’ blood
work to Biodiagnostic Testing Labs. Tr.
50–51.
6. Every month the lab test
representative would give the
Respondent an envelope of cash as
payment for her use of the lab. Id. at 51.
7. Over the course of two and a half
years, the Respondent received
$155,000 in payments from the testing
lab. Id.
8. The Respondent knew it was wrong
to take these payments at the time that
she accepted them. Id. at 52.
9. The Respondent eventually paid
taxes on these payments and forfeited
them. Id.
10. The Respondent continued to
accept the referral fees until the lab
owner and some of the lab
representatives were arrested on April
13, 2013. Id. at 53.
11. When the lab owner was arrested,
the Respondent knew that she was in
trouble for accepting the cash payments,
but that she did not know at the time
that the referral fees were illegal. Id. at
53–54.
12. The Respondent ‘‘never put a
needle in anyone’s arm to draw their
blood for any reason except for medical
necessity.’’ Id. at 55, 58. The
Respondent continued to send
bloodwork to other labs in the area,
without receiving a kickback from those
labs. Id. at 29–30.
13. The Respondent knew accepting
the cash payments was wrong as a tax
issue. Id. at 56.
14. The rate of blood work the
Respondent ordered was either less than
before or ‘‘there was essentially no
difference in the rate of ordering, in the
types of tests’’ after she started taking
the payments. Id. at –84.
15. There were 29 doctors prosecuted
in the Respondent’s criminal case. Tr.
65.
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
Respondent’s Acceptance of
Responsibility and Corrective Action
1. The Respondent testified that ‘‘I
blame myself only’’ and that ‘‘I was
responsible for all of it.’’ Id. at 57.
2. The Respondent admits that she
violated her fiduciary duty to her
patients. Id. at 56.
3. The Respondent presented her
cautionary story to medical students,
practicing physicians, health care ethics
students and educators. Id. at 61–62.
4. The Respondent was ordered by the
District Court to complete thirty
speaking engagements as community
service work over a period of two years.
GX 2, p. 2.
5. The Respondent completed the
thirty speaking engagements within six
months. Tr. 73.
6. The Respondent has completed
sixty-nine of these speaking
engagements as of the date of the DEA
hearing and continues to perform them.
Id. at 62–63, 66, 73.
7. The Respondent makes her
presentations to provide ‘‘restorative
justice’’ and ‘‘to try to make it up to my
community.’’ Id. at 63–64.
8. The Respondent refers to herself as
a felon because it is part of her story and
will never go away. Id. at 67, 75–76.
9. The Respondent accepts ‘‘one
hundred percent’’ responsibility for the
acts that led to her criminal conviction.
Id. at 74, 83.
10. The Respondent has never taken
the position that she did not commit the
crime to which she eventually pled
guilty. Id. at 83.
11. The Respondent believes her
criminal acts were serious violations of
the law. Id. at 74, 83.
12. The Respondent is remorseful for
her crime. Id. at 75.
13. The Respondent has been
excluded from Medicare and the State of
New York’s Medicaid program. Id. at
77–78.
14. The Respondent plans to reapply
to participate with Medicare and
Medicaid when her exclusion is over.
Id. at 77, 87.
15. Every doctor in the Respondent’s
criminal case went to prison except for
her and she believes her speaking
engagements made the difference in her
avoiding jail time. Id. at 88–89.
16. The Respondent completed her
probation on June 14, 2019. Id. at 89- 90.
P.R.
1. P.R. is a professor at Temple
University’s Lewis Katz School of
Medicine and the Center for Bioethics
Urban Health and Policy and also the
Assistant Director of the master’s
program in Urban Bioethics. Id. at 94.
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
24017
2. The Respondent has spoken to
several of P.R.’s classes including a PA
class, a class at Temple University that
included a variety of students, two
MSW classes and two classes of
undergraduate health care
administration students at Drexel
University. Id. at 96–97. Four of these
lectures were live, and not recorded. Id.
at 103.
3. The Respondent told these classes
her cautionary story and shared that she
is a convicted felon. Id. at 98.
Dr. J.G.
1. Dr. J.G. is a physician who practices
in obstetrics and gynecology. Id. at 108–
09.
2. The Respondent is Dr. J.G.’s best
friend and colleague, having met in
medical school. Id. at 108, 118.
3. Dr. J.G. plans to join the
Respondent in her office to practice
gynecology. Id. at 110.
4. The Respondent and Dr. J.G. refer
many patients to each other. Id. at 111.
5. When Dr. J.G. enters into a practice
arrangement with Respondent, she
expects they will share expenses equally
for staff, rent and utilities. Id. at 116–17.
6. According to Dr. J.G., the
Respondent has accepted responsibility
for her conduct. She is remorseful and
has made remarkable efforts to correct
her mistakes by cautioning others about
these real pitfalls. Id. at 114–115.
7. Dr. J.G. believes that the
Respondent possesses the necessary
ethics, intelligence and aptitude to
properly hold a registration and
administer and prescribe controlled
substances. Id. at 118.
Analysis
Credibility Analysis of Fact Witness:
The DI
The DI’s uncontroverted testimony,
while generally limited to the initiation
of the investigation and authentication
of the Government’s exhibits in this
matter, was consistent, genuine and
credible. The DI effectively explained
how the investigation of the Respondent
began, and how the DI verified the fact
of the Respondent’s exclusion from all
federal health care programs.
The DI, as a public servant, typically
has no personal stake in the outcome of
the instant investigation or in the
revocation of the Respondent’s
registration. I noted no animus on the
DI’s part as to the Respondent. Although
he may be viewed as being part of the
prosecution team, I saw no indication
from his testimony that any partiality
interfered with his reliable testimony.
Based on a complete review of the DI’s
presentation of testimony, I find his
testimony to be entirely credible.
E:\FR\FM\05MYN1.SGM
05MYN1
24018
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
Credibility Analysis of Fact Witness:
P.R.
P.R. is currently a professor at Temple
University’s Lewis Katz School of
Medicine and the Center for Bioethics
Urban Health and Policy. Tr. 94. She
also serves as the Assistant Director of
the Master’s program in Urban
Bioethics. Id. She met the Respondent
through an email the Respondent sent to
the Center for Urban Bioethics about a
year before P.R. started at the Center. Id.
at 95.
She has gotten to know the
Respondent throughout the course of
the Respondent’s presentations to P.R.’s
students. P.R. expressed that the
Respondent showed contrition during
her presentation. Id. at 100. She also
expressed that the Respondent
‘‘[a]bsolutely’’ accepted responsibility
for her actions. Id. at 100. P.R. indicated
that the Respondent ‘‘could not have
been more sincere.’’ Id. at 101. P.R.
expressed that it was clear from the
Respondent’s demeanor that she was
being truthful and honest about her
story. Id. at 102. There was no doubt in
P.R.’s mind that the Respondent was
absolutely sincere in her presentations.
Id.
P.R. presented clear and candid
testimony. She shared only a
professional relationship with the
Respondent. She appeared to be sincere
in her description of the Respondent’s
presentations and corroborated the
Respondent’s testimony. I find her
testimony to be entirely credible.
Credibility Analysis of Fact Witness:
Dr. J.G.
Dr. J.G. has prepared to move into the
Respondent’s private practice as a
gynecologist after a career working in
hospitals and academia. Id. at 108–10.
She met the Respondent during medical
school and they became close friends.
Id. at 110. They have been friends for
about 21 years. Id. at 118. She has
referred patients to the Respondent and
the Respondent has referred patients to
her. Id. at 111.
Dr. J.G. reports that she has observed
that the Respondent has accepted
responsibility for her conduct leading to
her conviction. Id. at 113–14. She has
observed the Respondent not only show
remorse for her conduct and try to better
understand what she did wrong, but
also go out to share her cautionary tale
to medical students and residents. Id. at
114–15. Based upon her professional
and personal interactions with the
Respondent, Dr. J.G. has found that the
Respondent is an excellent medical
diagnostician. Id. at 115. The
Respondent is a thorough clinician and
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
takes her time with each patient to
provide thorough medical care. Id. at
115–16. Dr. J.G. holds a DEA Certificate
of Registration and is familiar with the
responsibilities of being a registration
holder. Id. at 117–18. She believes that
the Respondent possesses all of the
necessary requirements, ethics,
judgment, and aptitude to hold a DEA
COR. Id. at 118.
Dr. J.G. presented clear and candid
testimony. She appeared to be sincere in
her description of the Respondent’s
remorse and acceptance of
responsibility, and corroborated the
Respondent’s testimony. Although they
have been lifelong friends and soon-tobe business partners, I do not find that
Dr. J.G. was unduly influenced by any
personal relationship, or financial gain,
or overt loyalty to the Respondent such
that it interfered with her testimony. I
find her testimony to be entirely
credible.
her criminal conviction and exclusion
from all federal health care programs.
The Respondent presented clear and
candid testimony. She appeared to be
sincere in her remorse and acceptance
of responsibility. Although the stakes
are very high in this proceeding, as the
Agency’s investigation and prosecution
could effectively preclude the
Respondent from practicing medicine,
the Respondent did not appear to color
her testimony. She appeared sincere and
authentic. Her commitment to remedial
efforts in the form of numerous
cautionary lectures to health care
professionals and to medical students is
probably the most convincing evidence
of the Respondent’s acceptance of
responsibility, remorse, and evidence
she is trustworthy of her responsibilities
as a possessor of a DEA COR. She
presented her testimony in a consistent
and convincing manner, and I find her
testimony to be entirely credible.
Credibility Analysis of Fact Witness:
Dr. Michele Martinho
Findings as to Allegations
The Government alleges that the
Respondent’s COR should be revoked
and any pending applications be denied
because the Respondent has been
excluded from all federal health care
programs, pursuant to 21 U.S.C.
824(a)(5). The Agency has held that
section 824(a)(5) authorizes the
revocation of existing registrations, as
well as the denial of applications.
Dinorah Drug Store, Inc., 61 FR 15972
(1996); Kuen H Chen, MD., 58 FR 65401
(1993).
In the adjudication of a revocation or
suspension of a DEA COR, DEA has the
burden of proving that the requirements
for such revocation or suspension are
satisfied. 21 CFR 1301.44(e) (2010).
Where the Government has sustained its
burden and made its prima facie case,
a respondent must both accept
responsibility for her actions and
demonstrate that she will not engage in
future misconduct. Patrick W Stodola,
MD., 74 FR 20727, 20734 (2009).
Acceptance of responsibility and
remedial measures are assessed in the
context of the ‘‘egregiousness of the
violations and the [DEA’s] interest in
deterring similar misconduct by [the]
Respondent in the future as well as on
the part of others.’’ David A. Ruben,
M.D., 78 FR 38363, 38364 (2013). Where
the Government has sustained its
burden, that registrant must present
sufficient mitigating evidence to assure
the Acting Administrator that he/she
can be entrusted with the responsibility
commensurate with such a registration.
Medicine Shoppe-Jonesborough, 73 FR
364387 (2008).*B
The Respondent explained the
circumstances leading up to her
underlying criminal conviction. She met
with a lab testing representative who
offered the Respondent referral fees to
send their laboratory bloodwork. Tr. 50–
51. The Respondent was paid every
month in cash by the representative. Id.
at 51. Over the course of two-and-a-half
years, she was paid $155,000, which the
Respondent indicated has been
forfeited, and the taxes paid. Id. at 51–
52, 55–56. On June 14, 2017, the
Respondent was found guilty in the
United States District Court for the
District of New Jersey of ‘‘Transporting
in Aid of Travel Act-Accepting Bribes in
Violation of the Travel Act,’’ in
violation of 18 U.S.C. 1952(a)(3) and 18
U.S.C. 2. See Stipulation 2.
The Respondent admitted that she
knew it was wrong to accept the
payments at the time she accepted them.
Id. at 52. Apart from copays, she had not
ever taken cash payments before that
time, and has not since. Id. The
Respondent asserted that while she now
understands that ignorance of the law is
no excuse, at the time, she did not fully
understand what bribery meant. Id. at
54–55. She stated that she never
conducted medically unnecessary blood
draws. Id. at 55. The Respondent
provided lengthy testimony that she has
fully accepted responsibility for her
conduct. She further testified as to her
remedial efforts and how she has
continued speaking engagements on her
own in order to share her story and help
prevent others from making the same
decisions that she made that resulted in
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
*B [Text
E:\FR\FM\05MYN1.SGM
omitted for brevity].
05MYN1
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
Exclusion Under U.S.C. 1320a–7(a)
The Government has alleged that the
Respondent has been excluded from
participation in a program pursuant to
section 1320a–7(a) of Title 42. The
Government can meet its burden under
§ 824(a)(5) simply by advancing
evidence that the registrant has been
excluded from a federal health care
program under 42 U.S.C. 1320a–7(a).
Johnnie Melvin Turner, MD., 67 FR
71203 (2002); Dinorah Drug Store, Inc.,
61 FR at 15973. The Administrator has
sanctioned registrants where the
Government introduced evidence of a
registrant/applicant’s plea agreement
and judgment, and the resulting letter of
exclusion from the U.S. Department of
Health and Human Services, Office of
Inspector General, imposing mandatory
exclusion under section 1320a–7(a). See
Richard Hauser, MD., 83 FR 26308
(2018).
Additionally, the Agency has
consistently held that the underlying
conviction that led to mandatory
exclusion does not need to involve
controlled substances to support a
revocation or denial. See, e.g.,
Mohammed Asgar, MD., 83 FR 29569
(2018); Narciso A. Reyes, MD., 83 FR
61678 (2018); Richard Hauser, M.D., 83
FR at 26308; Orlando Ortega-Ortiz,
M.D., 70 FR 15122 (2005); Juan PillotCostas, MD., 69 FR 62804 (2004).
However, evidence that the underlying
conviction does not relate to controlled
substances can be used in mitigation.
Mohammed Asgar, MD., 83 FR at 29573
(noting respondent’s conviction ‘‘did
not involve the misuse of his
registration to handle controlled
substances’’); Kwan Bo Jin, M.D., 77 FR
35021, 35027 (2012) (showing a lack of
evidence concerning respondent’s
‘‘prescribing practices’’). The Agency
must determine if a sanction is
appropriate where the record
demonstrates ‘‘questions as to the’’
registrant’s integrity. Anibal P. Herrera,
MD., 61 FR 65075, 65078 (1996).
Government’s Burden of Proof and
Establishment of a Prima Facie Case
Based upon my review of the
allegations by the Government, it is
necessary to determine if it has met its
prima facie burden of proving the
requirements for a sanction pursuant to
21 U.S.C. 824(a).
It is clear from the stipulations, the
Government’s evidence, and the
Respondent’s position in this matter
that there is no controversy between the
parties that the Respondent was
convicted of the underlying criminal
charge in the U.S. District Court for the
District of New Jersey, and was
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
subsequently mandatorily excluded
from all federal health care programs by
HHS/OIG, pursuant to 42 U.S.C. 1320a–
7(a). The Government’s evidence clearly
demonstrates the necessary elements of
proof under 21 U.S.C. 824(a)(5) and I
find that the Government has
established a prima facie case for
revocation of the Respondent’s COR and
denial of any pending applications.
Therefore, the remaining issue, and
the central focus for determination in
this matter, is whether the Respondent
has sufficiently demonstrated that she
has accepted responsibility for her
actions, has demonstrated remorse, and
has taken sufficient rehabilitative and
remedial steps to demonstrate to the
Acting Administrator that she can be
entrusted to maintain her COR. Kwan Bo
Jin, MD., 77 FR at 35021. The Agency
must determine whether revocation is
the appropriate sanction ‘‘to protect the
public from individuals who have
misused controlled substances or their
DEA Certificate of Registration and who
have not presented sufficient mitigating
evidence to assure the Administrative
that they can be trusted with the
responsibility carried by such a
registration.’’ Jeffrey Stein, M.D., 84 FR
46968, 46973 (2019) (quoting Leo R.
Miller, MD., 53 FR 21931, 21932 (1988)).
‘‘The Agency also looks to the nature of
the crime in determining the likelihood
of recidivism and the need for
deterrence.’’ Id. In determining whether
and to what extent a sanction is
appropriate, consideration must be
given to both the egregiousness of the
offenses established by the
Government’s evidence and the
Agency’s interest in both specific and
general deterrence. David A. Ruben,
M.D., 78 FR 38363, 38364, 38385
(2013).*C
Acceptance of Responsibility and
Rehabilitative Measures
The Government’s prima facie burden
having been met, [ ]*D the Respondent
must present sufficient mitigating
evidence to assure the Administrator
that she can be entrusted with the
responsibility incumbent with such
registration. Medicine Shoppe, 73 FR at
387; Samuel S. Jackson, 72 FR 23848,
23853 (2007). *[ ]The egregiousness and
extent of an applicant’s misconduct are
significant factors in determining the
appropriate sanction. See Jacobo
Dreszer, 76 FR 19386, 19387–88 (2011)
(explaining that a respondent can
‘‘argue that even though the
*C Analysis of public interest factors omitted for
relevance.
*D Omitted text for clarity and omitted text
throughout this section where noted with an
asterisk to remove the public interest analysis.
PO 00000
Frm 00106
Fmt 4703
Sfmt 4703
24019
Government has made out a prima facie
case, his conduct was not so egregious
as to warrant revocation’’); Paul H.
Vollanan, 73 FR 30630, 30644 (2008);
Gregory D. Owens, 74 FR 36751, 36757
n.22 (2009).
Since the exposure of the ‘‘kick-back’’
scheme, the Respondent has maintained
a consistent posture of acknowledging
the impropriety and illegality of her
actions, of cooperation with the
Government and of truly commendable
and extensive remedial efforts toward
her goal of ‘‘restorative justice.’’ She has
fully accepted responsibility for her
conduct, which led to the underlying
criminal conviction, both in her
criminal prosecution, as well as in the
instant proceeding. Tr. 83; FoF 33. The
Respondent testified credibly during the
hearing that ‘‘I blame myself only’’ and
that ‘‘I was responsible for all of it.’’ Tr.
57; FoF 24. When directly asked by
Government counsel during crossexamination if she accepted
responsibility, she stated that she
accepts ‘‘one-hundred percent’’
responsibility for the acts that led to her
criminal conviction. Tr. 74, 83; FoF 32.
The Respondent has further
demonstrated remorse for her crime. Tr.
75; FoF 35. She has repaid the bribes,
amended her tax returns, and paid the
taxes on the money she took. Tr. 52; FoF
17. As for her speaking engagements,
the Respondent has completed sixtynine speaking engagements, far beyond
the required thirty speaking
engagements ordered by the District
Court, and continues to complete
speaking engagements even though she
is no longer required to do so. Tr. 61–
63, 66, 73; GX 2, p.2; FoF 26–29. She
completed all requirements for her
probation on June 14, 2019. Tr. 89–90;
FoF 39. She has consistently
demonstrated that she has taken the
necessary steps to rehabilitate herself
and has demonstrated contrition for her
conduct that led to her underlying
conviction.
During the underlying criminal
proceedings, both the Assistant United
States Attorney (AUSA) and the
sentencing U.S. District Court Judge
believed that the Respondent had
accepted responsibility for her conduct.
The AUSA stated during the
Respondent’s sentencing hearing that
the Respondent ‘‘had demonstrated a
level of contrition that has been unique
among the many, many doctors that
we’ve dealt with in this case.’’ Tr. 68–
69; RX 9. Further, U.S. District Court
Judge Stanley R. Chesler found that the
E:\FR\FM\05MYN1.SGM
05MYN1
24020
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
Respondent had accepted responsibility.
RX 9.*E
Although correcting improper
behavior and practices is very important
to establish acceptance of responsibility,
conceding wrongdoing is critical to
reestablishing trust with the Agency.
Holiday CVS, L.L.C., 77 FR 62316,
62346 (2012); Daniel A. Glick, D.D.S., 80
FR at 74801. Based upon the evidence
presented, I find that the Respondent
has demonstrated the full measure of
acceptance of responsibility, and has
fully demonstrated that she is
remorseful of her actions and has taken
considerable rehabilitative steps to
ensure that this conduct will not be
repeated.
Loss of Trust
Where the Government has sustained
its burden and established that a
registrant has committed acts
inconsistent with the public interest,
that registrant must present sufficient
mitigating evidence to assure the Acting
Administrator that he can be entrusted
with the responsibility commensurate
with such a registration. Medicine
Shoppe, 73 FR at 387.
As demonstrated by the evidence
presented in this matter, it is clear to me
that the Respondent has unequivocally
accepted responsibility for her conduct.
She continues to not only improve
herself, but works to ensure that current
and future practitioners learn from her
past criminal conduct and will not make
the same choices. [I also find credible
Respondent’s statement that she would
‘‘never do anything to compromise [her]
license ever again.’’ Tr. 122.] Her
underlying criminal conduct did not
relate to her handling of controlled
substances and the Government has not
alleged any deficiencies by the
Respondent related to controlled
substances. The Government argues that
revocation in this matter is appropriate
for its deterrent effect. *[ ]*[Further,
although I am not bound by them in this
case, I agree with the statements of] U.S.
District Court Judge Chesler found that
‘‘in many ways your efforts may have as
much, if not more, impact than the
prosecutions per se because it sends out
a message and it sends out a message
from someone who has personally
impacted by having made the wrong
decision.’’ RX 9. It appears the
Respondent’s outreach to physicians,
*E Removed text. I agree with the Government that
the District Court’s findings on acceptance of
responsibility are not binding on this agency, see
Govt Posthearing Brief, at 9; however, I also agree
with the ALJ that these findings are relevant in that
they further support the ALJ’s finding of
Respondent’s credible acceptance of responsibility.
See Mohammed Asgar, MD., 83 FR at 29573 n.3.
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
medical staff and to students has
provided and continues to provide
valuable deterrence to the medical
community. The Respondent’s efforts
have greatly satisfied the need for
deterrence. At sentencing, the AUSA
stated that the Respondent’s ‘‘efforts
have been substantial, including the
speaking engagements that she’s been
involved with. I can tell you, your
Honor, that I have heard unsolicited
from folks in the medical field about the
work that she has been doing and folks
who are involved in educating
physicians and supervising physicians
have reported to me that her efforts have
made an impact in educating the
community, which is meaningful thing
from the government’s perspective.’’ RX
9. *[In this case,] the Respondent has
clearly demonstrated that she can be
entrusted to properly maintain her COR.
Recommendation
Considering the entire record before
me, the conduct of the hearing, and
observation of the testimony of the
witnesses presented, I find that the
Government has met its burden of proof
and has established a prima facie case
for revocation. However, *[ ] the
evidence overwhelmingly suggests that
the Respondent has unequivocally
accepted responsibility, is remorseful
for her conduct, has worked to
rehabilitate herself, has taken
extraordinary steps to educate medical
personnel and students, and has
presented convincing evidence
demonstrating that the Agency can
entrust her to maintain her COR.
Therefore, I recommend the
Respondent’s DEA COR BM9434440
should Not be Revoked and any pending
applications for renewal or modification
of such registration, or for additional
DEA registrations, be Granted
December 4, 2019
Mark M. Dowd,
U.S. Administrative Law Judge.
[FR Doc. 2021–09464 Filed 5–4–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 20–21]
Emmanuel A. Ayodele, M.D.; Decision
and Order
On April 29, 2020, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause (hereinafter, OSC) to Emmanuel
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
Ayodele, M.D. (hereinafter, Applicant)
of Compton, California. OSC, at 1. The
OSC proposed the denial of Applicant’s
application for a DEA Certificate of
Registration. Id. It alleged that
Applicant is without ‘‘authority to
handle controlled substances in
California, the state in which
[Applicant] seek[s] registration with
DEA.’’ Id. (citing 21 U.S.C. 824(a)(3)).
Specifically, the OSC alleged that the
Medical Board of California (hereinafter,
MBC) issued an order on February 3,
2020, revoking Applicant’s California
Physician’s and Surgeon’s Certificate.
Id. at 2. The OSC further alleged that,
because the Board revoked Applicant’s
medical license, Applicant lacks the
authority to handle controlled
substances in the State of California. Id.
The OSC notified Applicant of the
right to request a hearing on the
allegations or to submit a written
statement, while waiving the right to a
hearing, the procedures for electing each
option, and the consequences for failing
to elect either option. Id. at 2–3 (citing
21 CFR 1301.43). The OSC also notified
Applicant of the opportunity to submit
a corrective action plan. Id. at 3 (citing
21 U.S.C. 824(c)(2)(C)).
On June 24, 2020, Applicant, through
counsel, requested a hearing, stating
that Applicant ‘‘has filed a writ of
administrative mandate in the Superior
Court of California, San Francisco
Division . . . for judicial review of the
decision of the Medical Board of
California’’ and that ‘‘DEA should await
the final judgment.’’ Request for a
Hearing, at 1.
The Office of Administrative Law
Judges put the matter on the docket and
assigned it to Chief Administrative Law
Judge John J. Mulrooney II (hereinafter,
Chief ALJ), who issued an Order
Directing the Filing of Government
Evidence Regarding its Lack of State
Authority Allegation and Briefing
Schedule on June 25, 2020, with which
the Government complied by filing a
Motion for Summary Disposition
(hereinafter, Govt Motion) on July 7,
2020.
In its Motion, the Government
submitted evidence that the MBC
‘‘found [Applicant] non-compliant with
the probationary terms of its June 2017
order, ultimately resulting in the
revocation of his California Physician’s
and Surgeon’s Certificate.’’ Govt Motion,
at 3–4. Further, the Government noted
that the MBC had denied Applicant’s
Petition for Review of his revocation on
April 14, 2020. Id. In light of these facts,
the Government argued that DEA must
deny Applicant’s application. Id. at 5.
On July 15, 2020, Applicant filed
‘‘Applicant’s Reply’’ (hereinafter, App
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 86, Number 85 (Wednesday, May 5, 2021)]
[Notices]
[Pages 24012-24020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09464]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Michele L. Martinho, M.D.; Decision and Order
On December 4, 2019, the Drug Enforcement Administration
(hereinafter, DEA or Government) Administrative Law Judge Mark M. Dowd
(hereinafter, ALJ), issued a Recommended Rulings, Findings of Fact,
Conclusions of Law, and Decision of the Administrative Law Judge
(hereinafter, RD) on the action to revoke the DEA Certificate of
Registration Number BM9434440 of Michele L. Martinho, M.D. The ALJ
transmitted the record to me on January 7, 2020, and asserted that no
exceptions were filed by either party. ALJ Transmittal Letter, at 1.
Having reviewed and considered the entire administrative record before
me, I adopt the ALJ's RD with minor modifications, where noted herein.*
---------------------------------------------------------------------------
\*A\ I have made minor, nonsubstantive, grammatical changes to
the RD. Where I have made any substantive changes, omitted language
for brevity or relevance, or where I have added to or modified the
ALJ's opinion, I have bracketed the modified language and explained
the edit in a footnote marked with an asterisk and a letter in
alphabetical order.
---------------------------------------------------------------------------
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby dismiss the Order to Show Cause issued to
Michele L. Martinho, M.D. This Order is effective immediately.
D. Christopher Evans,
Acting Administrator.
Paul E. Soeffing, Esq., for the Government
Douglas M. Nadjari, Esq. and David Durso, Esq., for the Respondent
Recommended Rulings, Findings of Fact, Conclusions of Law, and Decision
of the Administrative Law Judge
The Assistant Administrator, Diversion Control Division, Drug
Enforcement Administration (DEA), issued an Order to Show Cause
(OSC),\1\ dated February 26, 2019, seeking to revoke the Respondent's
Certificate of Registration (COR), number BM9434440, pursuant to 21
U.S.C. 824(a)(5), and deny any applications for renewal or modification
of such registration and any applications for any other DEA
registrations pursuant to 21 U.S.C. 824(a)(5), because the Respondent
has been excluded from participation in a program pursuant to section
1320a-7(a) of Title 42. The Respondent requested a hearing on March 13,
2019,\2\ and prehearing proceedings were initiated.\3\ A hearing was
conducted in this matter on October 3, 2019, at the DEA Hearing
Facility in Arlington, Virginia.
---------------------------------------------------------------------------
\1\ ALJ Ex. 1.
\2\ ALJ Ex. 2.
\3\ ALJ Ex. 3.
---------------------------------------------------------------------------
The issue ultimately to be adjudicated by the Acting Administrator,
with the assistance of this recommended decision, is whether the record
as a whole establishes by a preponderance of the evidence that the
Respondent's subject registration with the DEA should be revoked
pursuant to 21 U.S.C. 824(a)(5).
After carefully considering the testimony elicited at the hearing,
the admitted exhibits, the arguments of counsel, and the record as a
whole, I have set forth my recommended findings of fact and conclusions
of law below.
The Allegations
In the OSC, the Government contends that the DEA should revoke the
Respondent's DEA COR because she has been excluded from participation
in a program pursuant to section 1320a-7(a) of Title 42.
Specifically, the Government alleges the following:
1. The Respondent is registered with the DEA as a practitioner in
Schedules II through V under DEA COR BM9434440. The Respondent's COR
expires by its terms on January 31, 2020.
2. On June 14, 2017, the Respondent was found guilty in the United
States District Court for the District of New Jersey of ``Transporting
in Aid of-Travel Act-Accepting Bribes in Violation of the Travel Act.''
Judgment was entered in U.S. v. Michele Martinho, No. 2:14-CR-00271-
SRC-1 (D.N.J. filed June 14, 2017).
3. Based on the Respondent's conviction, the U.S. Department of
Health and
Human Services, Office of Inspector General (``HHS/OIG''), by
letter dated July 31, 2018, mandatorily excluded the Respondent from
participation in Medicare, Medicaid, and all federal health care
programs for a minimum period of five years pursuant to 42 U.S.C.
1320a-7(a), effective August 20, 2018. Notwithstanding the fact that
the underlying conduct for which the Respondent was convicted had no
nexus to controlled substances, mandatory exclusion from Medicare,
Medicaid, and all federal health care programs by HHS/OIG warrants
revocation of the Respondent's registration pursuant to 21 U.S.C.
824(a)(5).
The Hearing
Government's Opening Statement
In the Government's Opening Statement, the Government indicated
that revocation is sought for the Respondent's COR involving Schedules
II through V, pursuant to 21 U.S.C. 824(a)(5). Tr. 10. The facts in
this matter are undisputed and have been stipulated to by the parties.
Id. The Respondent was found guilty in U.S. District Court of
transporting in aid of the Travel Act and accepting bribes in violation
of the Travel Act. Id. The following year, HHS/OIG mandatorily excluded
the Respondent from participation in Medicare, Medicaid, and all
federal health care programs. Id. at 10-11. Pursuant to 42 U.S.C.
1320a-7(a), the Respondent's exclusion remains in effect, which is the
basis upon which the DEA seeks to revoke the Respondent's COR. Id. at
11.
Respondent's Opening Statement
The Respondent asserted in her opening statement that this matter
is not about controlled substances, and it has nothing to do with the
issuance of prescriptions or record keeping for controlled substances.
Id. at 11. The Respondent admitted that the Government is correct that
she accepted cash payments in exchange for referring blood work to a
particular lab, that she pleaded guilty to a single count violation of
the Travel Act, and that she has been excluded by HHS/OIG from
participation in Medicare, Medicaid, and all federal health care
programs. Id. at 11-12. The Respondent maintained that the evidence
will show that the she can be entrusted to maintain and properly use
her DEA COR. Id. at 12. Revocation in this matter is not mandatory. Id.
at 12. The Respondent
[[Page 24013]]
asserted that she has accepted responsibility and has demonstrated that
she will not engage in misconduct again. Id. at 12.
Dr. Martinho completed courses of study in medical ethics before
her criminal proceedings began. Id. at 12-13. She also began to lecture
other doctors and medical students about her experiences to help
prevent them from making the same choices she did. Id. at 13-14. She
has given over 60 lectures during her own time and at her own expense.
Id. at 14. During her sentencing hearing at the U.S. District Court,
the presiding judge said that ``he felt that her talks had a greater
deterrent impact than anything that the court or the U.S. Attorney
could have done to prevent other people--to deter other people from
engaging in this kind of conduct.'' Id. at 14. Dr. Martinho's efforts
have been featured in the Washington Post, the Wall Street Journal, and
on NPR. Id. at 14. The Respondent submitted that the evidence will show
that she can be entrusted to maintain her DEA COR. Id. at 15. She has
used her COR properly throughout her life. Id. The Respondent argued
that the evidence will demonstrate that the Government's application to
revoke the Respondent's COR should be denied. Id.
Government's Case in Chief
Before presenting witnesses, the Government offered the sworn and
notarized COR history for the Respondent, which was admitted without
objection.\4\ See GX 1.\5\ The Government otherwise presented its case
in chief through the testimony of a single witness. The Government
presented the testimony of a Diversion Investigator (hereinafter, the
DI).\6\
---------------------------------------------------------------------------
\4\ The Respondent noted that all of the Government's evidence
had been stipulated to and that there were no objections to any of
the Government's exhibits. Tr. 18.
\5\ GX--Government Exhibit
\6\ The DI was called to sponsor the Government's exhibits. Tr.
18-19.
---------------------------------------------------------------------------
The DI
The DI is a Diversion Investigator for the DEA and has been
employed by the DEA for two years, currently assigned to the New York
Division. Tr. 20. He previously served with the New York City Police
Department for 23 years, retiring as a Detective Sergeant. Id. at 20.
He also served in the U.S. Army Reserves, retiring as a Lieutenant
Colonel. Id. at 20. He additionally served for four years in the United
Nations International Police Task Force in Kosovo, including one year
as a Regional Security Officer in Liberia and six months in Iraq
working with the Iraqi Police Department. Id. at 20. He has a
Bachelor's Degree from City College of New York. Id. at 21. The DI
indicated that he was assigned this matter by his group supervisor. Id.
at 22. The DI identified the criminal judgment in the criminal case of
U.S. v. Michele Martinho from the U.S. District Court in Newark, New
Jersey. Id. at 23; GX 2. He obtained a copy of the judgment via email
from the District Court. Tr. 23. Next, he identified a letter from the
HHS/OIG regarding the exclusion of the Respondent from all federal
health care programs. Id. at 24; GX 3. He obtained it via email from
the OIG. Tr. 25.
The DI identified a screenshot from the OIG's website that
demonstrated that the Respondent was still excluded from all federal
health care programs as of the morning of October 3, 2019, the date of
the hearing in this matter. Tr. 25-26; GX 4. He obtained this document
by going to the OIG's website and taking a screenshot of the
Respondent's information. Tr. 26. He verified the information on the
morning of the hearing by going to the OIG's website, entering the
Respondent's name, and confirmed that she was still excluded. Id. at
27.
Respondent's Case in Chief
Dr. Michele Martinho, M.D.
The Respondent currently lives in New York, where she has been
licensed to practice medicine since 2005. Id. at 29. The Respondent is
forty-five years old and has two children for whom the Respondent is
the primary caretaker. Id. at 45. She is first generation American,
with both of her parents being Portuguese immigrants. Id. She went to
Catholic school from grades K-12 and received her undergraduate degree
in psychology from New York University. She went on to attend Ross
University for medical school for two years in the Caribbean and
returned to the United States for her clinical rotations for the last
two years, from which she graduated in 2002. Id. at 47. She completed
her residency at Mount Sinai Elmhurst Hospital with a focus in internal
medicine, which lasted another three years. Id. After completing her
residency, she worked at a satellite clinic for the hospital for almost
three years in preparation for private practice. Id. at 48. She then
went into private practice and eventually purchased the practice. Id.
at 48-49. Her practice is located in the Lower East Side of Manhattan.
Id. at 49. It is surrounded by a significant amount of government
public housing whose tenants make up a large portion of her practice.
Id. Over the years, as the population of Manhattan has changed, her
patients have transitioned to younger patients. Id.
The Respondent explained the genesis of her involvement in the
criminal activity for which she was convicted. Id. at 50. Prior to her
purchasing the practice, the Respondent was introduced by a lab testing
representative to K.K., a sales representative for Biodiagnostic
Testing Laboratories (BIL), a blood testing lab. Id. at 29-30, 50. BIL
was located in New Jersey, but was looking to gain business in New
York. Id. at 50-51. The unnamed lab testing representative introduced
the Respondent to the owner of BIL. The three of them had dinner
together where they offered the Respondent what amounted to a referral
fee for referring bloodwork to their lab, to which the Respondent
conceded that such financial arrangement does not exist in the medical
field. Id. at 51.
She was paid every month by the laboratory's representative with an
envelope of cash. Id. Over the course of two and a half years, she
received $155,000. Id. at 51-52. When asked about the process that
resulted in the bribes, the Respondent explained that patients would
come into her office and she would conduct a blood draw on the patients
who needed it, including new patients. Id. at 80. She decided which lab
would get the blood depending on which insurance company the patient
had. Id. She testified that BTL lied to her and said they took all
insurances. When she found out that they did not take certain
insurances, she stopped sending certain patients' blood work to that
lab, because she did not want patients getting a bill. Id. She said
that either she or a member of her staff would conduct the draw and a
note would be placed in the patient's file designating the blood
testing lab. Id. at 80-81. She had billing software set up with the lab
so she could order the lab tests online. Id. at 81.
The Respondent stopped taking the cash payments once the laboratory
owner and a few laboratory representatives were arrested on April 13,
2013, for bribery. Id. at 53. The Respondent explained that while she
did not know that the referral fee was illegal, she did know that what
she was doing in taking the cash was wrong and admitted ``[t]hat I own
100 percent.'' Id. at 53-54. The Respondent admitted that she knew it
was wrong to accept the payments at the time she accepted them. Id. at
52. Although the Respondent did not realize that the referral fees
would be considered bribes under the law, she admitted that she
accepted the money and now realizes they constituted illegal
[[Page 24014]]
bribes. Id. at 51. The Respondent understood what she did was also
wrong from a moral standpoint. Id. at 56. She claimed that she
understood that she violated her fiduciary responsibility to her
patients, and that she had been questioned by patients at her practice
when they learned about the allegations. Id. She found that when she
was questioned by patients as to the medical necessity of the blood
draws and whether she had only done it for the money, it was a ``big
moment'' for her. Id. at 56-57, 58. She explained that a moderator at
one of the health care courses she has attended explained this
violation of patient trust aspect to her, and it has affected how she
has attempted to remediate herself. Id. at 57. She again claimed full
responsibility for her actions and did not place blame on the
laboratory or the laboratory representative. Id. When asked pointedly
by the Government whether she accepted responsibility for the acts that
led to her criminal conviction, the Respondent answered, ``[o]ne
hundred percent, yes.'' Id. at 74. She further confirmed that she
considers those criminal actions to be serious violations of the law
and that she is remorseful. Id. at 74-75. Apart from copays, she had
not ever taken cash payments before that time, and has not since. Id.
at 52.
The Respondent asserted that while she now understands that
ignorance of the law is no excuse, at the time, she did not fully
understand what bribery meant. Id. at 54-55. The Respondent ultimately
amended her tax returns and paid the taxes on the cash payments. As
part of her criminal sentence, the Respondent paid back the $155,000.
Id. at 52, 55-56. She stated that she never conducted medically
unnecessary blood draws. Id. at 55. As developed in her criminal case,
there was never any allegation by the Government that the blood testing
lacked medical necessity. Id. at 58.
The Government's investigation into BTL resulted in the prosecution
and conviction of a large number of physicians, including the
Respondent. Id. at 30. The Respondent cooperated with the Government in
the investigation and prosecution involving BTL. The Respondent
ultimately pled guilty to violating the federal Travel Act by accepting
bribes for sending some of her blood work to BTL. Id. at 30. The
Respondent continued to lawfully send blood work to two other
laboratories, including Quest Diagnostics and Bio Reference. Id. at 30-
31.
The Respondent testified that her federal criminal case did not
involve controlled substances, prescriptions for controlled substances,
or record keeping for controlled substances. Id. at 31. She has never
before been disciplined or sanctioned for her prescribing methods with
respect to controlled substances or her record keeping practices. Id.
The Respondent discussed each of her proposed documentary evidentiary
exhibits.\7\ Id. at 31-32. The Respondent identified a presentencing
memorandum given to the District Court judge before her sentencing in
2017. Id. at 32; RX 1.\8\ The Respondent identified a flyer for Boston
Medical Center, which advertised an event, in which she was the keynote
speaker for their Ethics and Compliance Week in 2017. Tr. 33; RX 2. The
Respondent indicated that this was an example of the type of lectures
she has given and continues to give, as discussed in her opening
statement. The flyer included a picture, a description of the crime of
conviction and the purpose of the lecture. Id. at 33.
---------------------------------------------------------------------------
\7\ The Government did not object to any of the Respondent's
proposed documentary evidence.
\8\ RX--Respondent's Exhibit
---------------------------------------------------------------------------
The Respondent offered a letter from Dr. B.F., who is an orthopedic
surgeon at MD Anderson. Tr. 34; RX 3. Dr. B.F. invited the Respondent
to speak with his orthopedic fellows to tell her story and hopefully
deter them from engaging in similar behavior for which she had been
convicted. Tr. 34. It was submitted to the District Court in
conjunction with the presentencing memorandum. Id.; see RX 1. The
Respondent offered a letter from Dr. J.E., a professor of philosophy at
Marin University. Tr. 35-36; RX 4. The Respondent contacted him and
offered to give her presentation to his medical students, which he
accepted. Tr. 36. It was also submitted to the District Court in
conjunction with the presentencing memorandum. Id.
The Respondent offered a letter from J.W., an ethics professor from
Ohio University. Tr. 36-37; RX 5. J.W. arranged for the Respondent to
provide a radio presentation on NPR regarding her crime. Tr. 37. The
Respondent offered a newspaper article from the Washington Post,
featuring the Respondent and her presentation at Georgetown University.
Tr. 38; RX 6. The Respondent offered certificates for completion of
programs in health care ethics. Tr. 39-41; RX 7, 8. The Respondent
offered the transcript of her sentencing hearing before the U.S.
District Court conducted on June 14, 2017. Tr. 41; RX 9.
Finally, the Respondent offered a consent agreement between her and
the New York State Department of Health State Board for Professional
Medical Conduct. Tr. 42; RX 10. The Respondent explained that after her
sentencing in the District Court, a pre-hearing was conducted with the
New York State Department of Health, Office of Professional and Medical
Conduct, and based upon her efforts at remediation, the Respondent was
allowed to continue practicing medicine with no interruptions or
restrictions placed on her state license. Tr. 44-45.
Following completion of her ethical course of study at Creighton
University, the Respondent discovered that the prosecutor on her
criminal case was going to law schools to discuss health care fraud.
She offered to go with the prosecutor and tell her side of the story to
the students. Tr. 60-61. While the prosecutor declined her invitation,
she began to research medical schools, law schools, ethics societies,
and medical societies to share her story to whomever would listen and
would benefit from her presentation. Id. at 61-62. She sent out a cold
email and offered to pay her own travel and expenses for the
opportunity to share her story, which has cost approximately $20,000,
in addition to taking her away from her current practice. Id. at 62,
68, 74. As of the date of the instant hearing, the Respondent indicated
that she had completed sixty-nine of these speaking engagements and
continues to do them. Id. at 62-63.
The Respondent discovered ``restorative justice'' during one of her
medical ethics courses and began to focus on that. Id. at 63-64. She
found it was not just about being sorry for your conduct, but how she
could do better and correct her mistake. Id. at 64. She explained that
she understood her crime had affected her patients, other physicians,
and the community. Id. at 64-65. The Respondent indicated that medical
school does not adequately prepare students for these real-life issues
and that she wanted to share her experience as an example. Id. at 65.
The Respondent reported that J.W. (see RX 5) was an educator of health
care ethics, and that J.W. told the Respondent that she was changing
her curriculum to include scenarios such as the Respondent's
experience. Id. The Respondent further advised that at one of the
schools she spoke, New York Medical College, they established a medical
legal course for their law students and medical students to discuss
situations similar to the Respondent's in order to better prepare their
students. Id. at 66.
The Respondent opened her presentation by giving her name,
explaining that she is an internal medicine physician from New York,
and that she was convicted of a crime in 2014, referring to herself as
a felon. Id. at 67. She testified that she always refers
[[Page 24015]]
to herself as a felon as that is part of her story. Id. The Respondent
noted statements made by the prosecutor, the sentencing judge, and
probation department during her sentencing hearing in support of the
Respondent and her remedial actions taken since pleading guilty. Tr.
68-71; RX 9, pp. 9, 13-14.
The Respondent was questioned regarding whether the underlying
criminal conduct was ``aberrational'' and how she can be entrusted to
maintain her DEA COR. Id. at 71-72. The Respondent testified that for
the past six years, she has been able to reach thousands of medical
students and physicians. Id. at 72. She said that some of her
presentations at universities have been recorded and are required to be
watched by students, so she knows she is making an impact on medicine
in this way. Id. She stated that she wants to continue in her
profession because it is what she has wanted for her entire life. Id.
When questioned, she indicated that while she had been ordered to
complete thirty lectures by the sentencing judge, she had already
completed twenty-six speaking engagements by the date of the sentencing
hearing. Id. at 73. She was ordered to complete thirty presentations
within two years of sentencing, which she completed in only six months.
Id. She further indicated that she has no plans to stop doing her
speaking engagements, even though her probation term ended on June 14,
2019. Id. at 73-77, 90.
She further offered her cooperation to a number of government
agencies as part of her remedial efforts. Tr. 85-87; RX 1, p. 463. She
testified that she brought information concerning other potential
criminal activity to approximately seven other state and federal law
enforcement agencies across the federal government and two states, for
which she received a 5K reduction letter for those efforts.\9\ Tr. 87.
The Respondent scored a level 19 of the sentencing guidelines, which
would normally carry a punishment of thirty to thirty-seven months in
prison. Id. at 88. The prosecutors in the criminal case filed a 5K1
recommendation letter, which recommended that she be sentenced within a
guideline level which would make her probation eligible. Id. at 88-89.
She stated that every other physician involved in the matter went to
prison. Id. at 89.
---------------------------------------------------------------------------
\9\ A ``5K reduction'' refers to USSG Sec. 5Kl.l--Substantial
Assistance to Authorities. Upon motion of the Government stating
that the defendant has provided substantial assistance in the
investigation or prosecution of another person who has committed an
offense, the court may depart from the guidelines.
---------------------------------------------------------------------------
The Respondent indicated that she plans to reapply to participate
in Medicare and Medicaid when her exclusion is over. Id. at 77. She
explained that she had been excluded from Medicare, Medicaid, and the
State of New York's Medicaid program, which she appealed and had
rescinded. Id. at 77-78. She stated that she had been excluded from the
state program even though she hadn't been participating in the program
following her residency. Id. at 78-79.
When I asked the Respondent if she had ever before taken the
position that she did not commit the bribery, she responded, no, she
had never taken that position, nor the position that bribery was not a
serious offense warranting punishment. Id. at 83. She testified that
after she had found out she had committed a crime, she had her office
manager pick a random selection of patients to determine whether the
rate of ordering bloodwork had increased at all based on the bribes.
Id. at 84. The office manager picked one-hundred random patients
established before the Respondent purchased the practice, one-hundred
new patients before using BTL, and one-hundred new patients after
starting to use BTL. Id. The office manager found that there was
essentially no difference in the rate or frequency of ordering or what
types of tests were ordered. Id. at 84.
I asked why she believed that the Acting Administrator should trust
her with her COR. Id. at 121. The Respondent asserted credibly that her
efforts over the past six years is evidence of her contrition and
trying to ``pay it forward to the next generation of physicians.'' Id.
at 121-22. She cannot imagine repeating any part of her life from the
past six years due to fear of going to jail, not being able to support
her children, or not being able to take care of them. Id. at 122. She
expressed that she would ``never do anything to compromise [her]
license ever again.'' Id.
P.R., J.D., M.S.W., M.Bioethics
P.R. is currently a professor at Temple University's Lewis Katz
School of Medicine and the Center for Bioethics Urban Health and
Policy. Id. at 94. She also serves as the Assistant Director of the
Master's program in Urban Bioethics. Id. She received her bachelor's
degree in political science, a master's degree in social work from the
University of Pennsylvania, School of Social Policy and Practice, and a
law degree from Temple University's law school. Id. at 93. She has
previously taught at Drexel University, Simmons College, and previously
worked as a geriatric social worker for approximately five years. Id.
at 94.
P.R. met the Respondent through an email the Respondent sent to the
Center for Urban Bioethics approximately one year before P.R. started
at the Center. Id. at 95. After a review of the Respondent's email,
P.R. contacted the Respondent to hear more about her experiences and to
determine if it would be appropriate for the Respondent to come to the
University and speak to the students. Id. at 95. P.R. found that the
Respondent's experience ``would be a good fit for their program'' and
she invited the Respondent to come and talk to her class of physician
assistants in the summer of 2017. Id. at 96. Since that time, the
Respondent has spoken to several classes at Temple University. P.R.
also invited her to speak to her students at Simmons College, including
social work students, and undergraduate health care administration
students at Drexel University. Id. at 97.
P.R. described the Respondent's lecture and her presentation to the
students. Id. at 97-98. She found the Respondent's story very ``honest,
raw, and compelling.'' Id. at 97. The Respondent did not minimize her
actions or try to make excuses, but explained what she had done and how
it had happened. Id. at 98-99. The Respondent explained that apart from
the medical knowledge required of health care professionals, it is also
important to ``have a sense of how to run a business'' and other
necessary considerations before entering the health care field. Id. at
98.
P.R. expressed that the Respondent showed contrition during her
presentation. Id. at 100. She also expressed that the Respondent
``[a]bsolutely'' accepted responsibility for her actions. Id.. She
found that the Respondent's reputation among the students was one of
respect for being candid about her story, and that the students found
her talk to be very relevant to their education, and what it looks like
to be confronted with ethical decisions in the field. Id. at 100-01.
I asked P.R. if the Respondent appeared sincere in her
presentations to students. Id. at 101. P.R. indicated that the
Respondent ``could not have been more sincere.'' Id. P.R. expressed
that it was clear from the Respondent's demeanor that she was being
truthful and honest about her story. Id. at 102. There was no doubt in
P.R.'s mind that she was absolutely sincere in her presentations. Id.
The Respondent gave live presentations twice at the Center for Urban
Bioethics. She gave four live
[[Page 24016]]
presentations for P.R. in total. Id. at 102-03. She found that the
Respondent's talk was beneficial to the students as it demonstrated
what a real-world ethical dilemma looks like and not only showed the
consequences of making a bad decision, but also what a person can do to
correct their mistake. Id. at 103-04. P.R. explained what she perceived
to be a lack of ethical training in medical school, and found that the
Respondent's presentations provided a bridge between this gap. Id. at
104-06. P.R. stated that the Respondent is ``exactly the type of doctor
I would want to have'' and that ``we're wanting our students to be.''
Id. at 105.
Dr. J.G., M.D.
Dr. J.G. received her undergraduate degree from Stony Brook, her
master's degree from Brooklyn College, and finally her medical degree
at Ross University. Id. at 108. She completed her residency in
obstetrics and gynecology at George Washington University. Tr. Id.
Afterwards, she began working at Columbia University, Columbia
Presbyterian in the Allen Pavilion for two years. Id. at 109. She then
joined Mt. Sinai Hospital and Icahn School of Medicine as an Assistant
Professor in obstetrics, gynecology, reproduction, endocrine and
fertility, and minimally invasive surgery, where she worked until the
end of 2013. Id. She went on to BronxCare Health System as an Assistant
Professor in obstetrics and gynecology. Id. After her time in academia,
she moved into private practice at Maiden Lane Medical before presently
moving to join the Respondent at the Respondent's practice as a
gynecologist. Id. at 110.
Dr. J.G. met the Respondent during medical school and they became
close friends. Id. They have been friends for about 21 years. Id. at
118. She has referred patients to the Respondent and the Respondent has
referred patients to her. Id. at 111. Dr. J.G. opined that the
Respondent provides excellent care to her patients, is a very thorough
and excellent clinician, and that she trusts the Respondent with their
care. Id. at 111. Dr. J.G. has found that her patients greatly enjoy
being treated by the Respondent. Id. at 111-12. Despite being aware of
the Respondent's conviction and the circumstances surrounding it, Dr.
J.G. continues to refer patients to the Respondent. Id. at 112. From
her observations, she found that one particular patient was
``remarkably healthier'' after being treated by the Respondent. Id.
Dr. J.G. says that she has personally observed that the Respondent
has accepted responsibility for the conduct which led to her
conviction. Id. at 113-14. She has observed the Respondent not only
show remorse for her conduct and to try and better understand what she
did wrong, but that the Respondent has gone out to share her
experiences with medical students and residents. Id. at 114-15. Dr.
J.G. reiterated that ethics education is lacking in medical school, and
she found the Respondent's lectures to be ``beyond remarkable.'' Id. at
115. Based upon her professional and personal interactions with the
Respondent, Dr. J.G. has found that the Respondent is an excellent
judge of medical treatment. Id. at 115. The Respondent is a thorough
clinician and takes her time with each patient to provide thorough
treatment. Id. at 115-16. Although Dr. J.G. is preparing to join the
Respondent's practice, she does not currently have a financial
relationship with the Respondent. Tr. 116. When she refers patients to
the Respondent, there is no referral fee or fee sharing and Dr. J.G.
noted that that is illegal within the profession. Id. at 117. When Dr.
J.G. enters into a practice arrangement with the Respondent, she
expects they will share expenses equally for staff, rent and utilities.
Id. at 116-17.
Dr. J.G. holds a DEA Certificate of Registration and is familiar
with the responsibilities of being a registration holder. Id. at 117-
18. She believes that the Respondent possesses all of the necessary
requirements, ethics, judgment, and aptitude to hold a DEA COR. Id. at
118.
The Facts
Stipulations of Fact
The Government and the Respondent have agreed to five stipulations,
which I recommend be accepted as fact in these proceedings:
1. Respondent is registered with the DEA as a practitioner in
Schedules II through V under DEA Certificate of Registration BM9434440
with a registered address of 308A East 15 Street, New York, NY 10003,
and a mailing address of 20 River Terrace, Apt. 23E, New York, NY
10282. Respondent's registration expired by its terms on January 31,
2020.
2. On June 14, 2017, Respondent was found guilty in the United
States District Court for the District of New Jersey of ``Transporting
in Aid of Travel Act-Accepting Bribes in Violation of the Travel Act,''
in violation of 18 U.S.C. 1952(a)(3) and 18 U.S.C. 2. Judgment was
entered against Respondent in U.S. v. Michele Martinho, No. 2:14-CR-
00271-SRC-1 (D.N.J. filed June 14, 2017).
3. Based on Respondent's conviction, the U.S. Department of Health
and Human Services, Office of Inspector General (``HHS/OIG''), by
letter dated July 31, 2018, mandatorily excluded Respondent from
participation in Medicare, Medicaid and all federal health care
programs for the minimum period of five years pursuant to 42 U.S.C.
1320a-7(a), effective August 20, 2018.
4. Reinstatement of eligibility to participate in Medicare,
Medicaid and all federal health care programs after exclusion by HHS/
OIG is not automatic.
5. Respondent is currently excluded from participation in Medicare,
Medicaid and all federal health care programs.
Findings of Fact
The factual findings (FoF) below are based on a preponderance of
the evidence, including the detailed, credible, and competent testimony
of the aforementioned witnesses, the exhibits entered into evidence,
and the record before me.
1. The Respondent currently holds DEA COR BM9434440 in Schedules II
through V with a registered address of 308A East 15 Street, New York,
NY 10003, and a mailing address of 20 River Terrace, Apt. 23E, New
York, NY 10282. The Respondent's COR expires by its terms on January
31, 2020. ALJ Ex. 1, 9.
2. The Respondent received her undergraduate degree in psychology
from New York University. Id. at 47.
3. The Respondent attended Ross University for medical school and
returned to the United States for her clinical rotations, from which
she graduated in 2002. Id. at 47.
4. The Respondent completed her residency at Mount Sinai Elmhurst
Hospital with a focus in internal medicine. Id. at 47.
5. The Respondent worked at a satellite clinic for the hospital for
almost three years after her residency. Id. at 48.
6. The Respondent went into private practice and eventually
purchased the practice, which is an internal medicine practice on the
Lower East Side of Manhattan. Id. at 48-49.
7. The Respondent has been licensed to practice medicine in the
state of New York since 2005. Id. at 29; RX 10.
Respondent's Criminal Act, Conviction, and Exclusion
1. The Respondent pled guilty to ``[v]iolating the federal Travel
Act for accepting bribes for sending [her patients'] blood work to a
laboratory.'' Tr. 30. She was sentenced to probation for a period of
two years, of which the
[[Page 24017]]
first twelve months were served in home confinement. RX 9.
2. The Respondent has never been disciplined or sanctioned
concerning her prescribing of controlled substances. Tr. 30.
3. The Respondent's conviction did not involve any controlled
substances. Id. at 31.
4. After her sentencing in her criminal case, the New York State
Department of Health, Office of Professional and Medical Conduct,
allowed the Respondent ``to continue to practice medicine with no
interruption and no restriction.'' Id. at 44-45; RX 10.
5. The Respondent accepted a referral fee or bribe to send her
patients' blood work to Biodiagnostic Testing Labs. Tr. 50-51.
6. Every month the lab test representative would give the
Respondent an envelope of cash as payment for her use of the lab. Id.
at 51.
7. Over the course of two and a half years, the Respondent received
$155,000 in payments from the testing lab. Id.
8. The Respondent knew it was wrong to take these payments at the
time that she accepted them. Id. at 52.
9. The Respondent eventually paid taxes on these payments and
forfeited them. Id.
10. The Respondent continued to accept the referral fees until the
lab owner and some of the lab representatives were arrested on April
13, 2013. Id. at 53.
11. When the lab owner was arrested, the Respondent knew that she
was in trouble for accepting the cash payments, but that she did not
know at the time that the referral fees were illegal. Id. at 53-54.
12. The Respondent ``never put a needle in anyone's arm to draw
their blood for any reason except for medical necessity.'' Id. at 55,
58. The Respondent continued to send bloodwork to other labs in the
area, without receiving a kickback from those labs. Id. at 29-30.
13. The Respondent knew accepting the cash payments was wrong as a
tax issue. Id. at 56.
14. The rate of blood work the Respondent ordered was either less
than before or ``there was essentially no difference in the rate of
ordering, in the types of tests'' after she started taking the
payments. Id. at -84.
15. There were 29 doctors prosecuted in the Respondent's criminal
case. Tr. 65.
Respondent's Acceptance of Responsibility and Corrective Action
1. The Respondent testified that ``I blame myself only'' and that
``I was responsible for all of it.'' Id. at 57.
2. The Respondent admits that she violated her fiduciary duty to
her patients. Id. at 56.
3. The Respondent presented her cautionary story to medical
students, practicing physicians, health care ethics students and
educators. Id. at 61-62.
4. The Respondent was ordered by the District Court to complete
thirty speaking engagements as community service work over a period of
two years. GX 2, p. 2.
5. The Respondent completed the thirty speaking engagements within
six months. Tr. 73.
6. The Respondent has completed sixty-nine of these speaking
engagements as of the date of the DEA hearing and continues to perform
them. Id. at 62-63, 66, 73.
7. The Respondent makes her presentations to provide ``restorative
justice'' and ``to try to make it up to my community.'' Id. at 63-64.
8. The Respondent refers to herself as a felon because it is part
of her story and will never go away. Id. at 67, 75-76.
9. The Respondent accepts ``one hundred percent'' responsibility
for the acts that led to her criminal conviction. Id. at 74, 83.
10. The Respondent has never taken the position that she did not
commit the crime to which she eventually pled guilty. Id. at 83.
11. The Respondent believes her criminal acts were serious
violations of the law. Id. at 74, 83.
12. The Respondent is remorseful for her crime. Id. at 75.
13. The Respondent has been excluded from Medicare and the State of
New York's Medicaid program. Id. at 77-78.
14. The Respondent plans to reapply to participate with Medicare
and Medicaid when her exclusion is over. Id. at 77, 87.
15. Every doctor in the Respondent's criminal case went to prison
except for her and she believes her speaking engagements made the
difference in her avoiding jail time. Id. at 88-89.
16. The Respondent completed her probation on June 14, 2019. Id. at
89- 90.
P.R.
1. P.R. is a professor at Temple University's Lewis Katz School of
Medicine and the Center for Bioethics Urban Health and Policy and also
the Assistant Director of the master's program in Urban Bioethics. Id.
at 94.
2. The Respondent has spoken to several of P.R.'s classes including
a PA class, a class at Temple University that included a variety of
students, two MSW classes and two classes of undergraduate health care
administration students at Drexel University. Id. at 96-97. Four of
these lectures were live, and not recorded. Id. at 103.
3. The Respondent told these classes her cautionary story and
shared that she is a convicted felon. Id. at 98.
Dr. J.G.
1. Dr. J.G. is a physician who practices in obstetrics and
gynecology. Id. at 108-09.
2. The Respondent is Dr. J.G.'s best friend and colleague, having
met in medical school. Id. at 108, 118.
3. Dr. J.G. plans to join the Respondent in her office to practice
gynecology. Id. at 110.
4. The Respondent and Dr. J.G. refer many patients to each other.
Id. at 111.
5. When Dr. J.G. enters into a practice arrangement with
Respondent, she expects they will share expenses equally for staff,
rent and utilities. Id. at 116-17.
6. According to Dr. J.G., the Respondent has accepted
responsibility for her conduct. She is remorseful and has made
remarkable efforts to correct her mistakes by cautioning others about
these real pitfalls. Id. at 114-115.
7. Dr. J.G. believes that the Respondent possesses the necessary
ethics, intelligence and aptitude to properly hold a registration and
administer and prescribe controlled substances. Id. at 118.
Analysis
Credibility Analysis of Fact Witness: The DI
The DI's uncontroverted testimony, while generally limited to the
initiation of the investigation and authentication of the Government's
exhibits in this matter, was consistent, genuine and credible. The DI
effectively explained how the investigation of the Respondent began,
and how the DI verified the fact of the Respondent's exclusion from all
federal health care programs.
The DI, as a public servant, typically has no personal stake in the
outcome of the instant investigation or in the revocation of the
Respondent's registration. I noted no animus on the DI's part as to the
Respondent. Although he may be viewed as being part of the prosecution
team, I saw no indication from his testimony that any partiality
interfered with his reliable testimony. Based on a complete review of
the DI's presentation of testimony, I find his testimony to be entirely
credible.
[[Page 24018]]
Credibility Analysis of Fact Witness: P.R.
P.R. is currently a professor at Temple University's Lewis Katz
School of Medicine and the Center for Bioethics Urban Health and
Policy. Tr. 94. She also serves as the Assistant Director of the
Master's program in Urban Bioethics. Id. She met the Respondent through
an email the Respondent sent to the Center for Urban Bioethics about a
year before P.R. started at the Center. Id. at 95.
She has gotten to know the Respondent throughout the course of the
Respondent's presentations to P.R.'s students. P.R. expressed that the
Respondent showed contrition during her presentation. Id. at 100. She
also expressed that the Respondent ``[a]bsolutely'' accepted
responsibility for her actions. Id. at 100. P.R. indicated that the
Respondent ``could not have been more sincere.'' Id. at 101. P.R.
expressed that it was clear from the Respondent's demeanor that she was
being truthful and honest about her story. Id. at 102. There was no
doubt in P.R.'s mind that the Respondent was absolutely sincere in her
presentations. Id.
P.R. presented clear and candid testimony. She shared only a
professional relationship with the Respondent. She appeared to be
sincere in her description of the Respondent's presentations and
corroborated the Respondent's testimony. I find her testimony to be
entirely credible.
Credibility Analysis of Fact Witness: Dr. J.G.
Dr. J.G. has prepared to move into the Respondent's private
practice as a gynecologist after a career working in hospitals and
academia. Id. at 108-10. She met the Respondent during medical school
and they became close friends. Id. at 110. They have been friends for
about 21 years. Id. at 118. She has referred patients to the Respondent
and the Respondent has referred patients to her. Id. at 111.
Dr. J.G. reports that she has observed that the Respondent has
accepted responsibility for her conduct leading to her conviction. Id.
at 113-14. She has observed the Respondent not only show remorse for
her conduct and try to better understand what she did wrong, but also
go out to share her cautionary tale to medical students and residents.
Id. at 114-15. Based upon her professional and personal interactions
with the Respondent, Dr. J.G. has found that the Respondent is an
excellent medical diagnostician. Id. at 115. The Respondent is a
thorough clinician and takes her time with each patient to provide
thorough medical care. Id. at 115-16. Dr. J.G. holds a DEA Certificate
of Registration and is familiar with the responsibilities of being a
registration holder. Id. at 117-18. She believes that the Respondent
possesses all of the necessary requirements, ethics, judgment, and
aptitude to hold a DEA COR. Id. at 118.
Dr. J.G. presented clear and candid testimony. She appeared to be
sincere in her description of the Respondent's remorse and acceptance
of responsibility, and corroborated the Respondent's testimony.
Although they have been lifelong friends and soon-to-be business
partners, I do not find that Dr. J.G. was unduly influenced by any
personal relationship, or financial gain, or overt loyalty to the
Respondent such that it interfered with her testimony. I find her
testimony to be entirely credible.
Credibility Analysis of Fact Witness: Dr. Michele Martinho
The Respondent explained the circumstances leading up to her
underlying criminal conviction. She met with a lab testing
representative who offered the Respondent referral fees to send their
laboratory bloodwork. Tr. 50-51. The Respondent was paid every month in
cash by the representative. Id. at 51. Over the course of two-and-a-
half years, she was paid $155,000, which the Respondent indicated has
been forfeited, and the taxes paid. Id. at 51-52, 55-56. On June 14,
2017, the Respondent was found guilty in the United States District
Court for the District of New Jersey of ``Transporting in Aid of Travel
Act-Accepting Bribes in Violation of the Travel Act,'' in violation of
18 U.S.C. 1952(a)(3) and 18 U.S.C. 2. See Stipulation 2.
The Respondent admitted that she knew it was wrong to accept the
payments at the time she accepted them. Id. at 52. Apart from copays,
she had not ever taken cash payments before that time, and has not
since. Id. The Respondent asserted that while she now understands that
ignorance of the law is no excuse, at the time, she did not fully
understand what bribery meant. Id. at 54-55. She stated that she never
conducted medically unnecessary blood draws. Id. at 55. The Respondent
provided lengthy testimony that she has fully accepted responsibility
for her conduct. She further testified as to her remedial efforts and
how she has continued speaking engagements on her own in order to share
her story and help prevent others from making the same decisions that
she made that resulted in her criminal conviction and exclusion from
all federal health care programs.
The Respondent presented clear and candid testimony. She appeared
to be sincere in her remorse and acceptance of responsibility. Although
the stakes are very high in this proceeding, as the Agency's
investigation and prosecution could effectively preclude the Respondent
from practicing medicine, the Respondent did not appear to color her
testimony. She appeared sincere and authentic. Her commitment to
remedial efforts in the form of numerous cautionary lectures to health
care professionals and to medical students is probably the most
convincing evidence of the Respondent's acceptance of responsibility,
remorse, and evidence she is trustworthy of her responsibilities as a
possessor of a DEA COR. She presented her testimony in a consistent and
convincing manner, and I find her testimony to be entirely credible.
Findings as to Allegations
The Government alleges that the Respondent's COR should be revoked
and any pending applications be denied because the Respondent has been
excluded from all federal health care programs, pursuant to 21 U.S.C.
824(a)(5). The Agency has held that section 824(a)(5) authorizes the
revocation of existing registrations, as well as the denial of
applications. Dinorah Drug Store, Inc., 61 FR 15972 (1996); Kuen H
Chen, MD., 58 FR 65401 (1993).
In the adjudication of a revocation or suspension of a DEA COR, DEA
has the burden of proving that the requirements for such revocation or
suspension are satisfied. 21 CFR 1301.44(e) (2010). Where the
Government has sustained its burden and made its prima facie case, a
respondent must both accept responsibility for her actions and
demonstrate that she will not engage in future misconduct. Patrick W
Stodola, MD., 74 FR 20727, 20734 (2009). Acceptance of responsibility
and remedial measures are assessed in the context of the
``egregiousness of the violations and the [DEA's] interest in deterring
similar misconduct by [the] Respondent in the future as well as on the
part of others.'' David A. Ruben, M.D., 78 FR 38363, 38364 (2013).
Where the Government has sustained its burden, that registrant must
present sufficient mitigating evidence to assure the Acting
Administrator that he/she can be entrusted with the responsibility
commensurate with such a registration. Medicine Shoppe-Jonesborough, 73
FR 364387 (2008).\*B\
---------------------------------------------------------------------------
\*B\ [Text omitted for brevity].
---------------------------------------------------------------------------
[[Page 24019]]
Exclusion Under U.S.C. 1320a-7(a)
The Government has alleged that the Respondent has been excluded
from participation in a program pursuant to section 1320a-7(a) of Title
42. The Government can meet its burden under Sec. 824(a)(5) simply by
advancing evidence that the registrant has been excluded from a federal
health care program under 42 U.S.C. 1320a-7(a). Johnnie Melvin Turner,
MD., 67 FR 71203 (2002); Dinorah Drug Store, Inc., 61 FR at 15973. The
Administrator has sanctioned registrants where the Government
introduced evidence of a registrant/applicant's plea agreement and
judgment, and the resulting letter of exclusion from the U.S.
Department of Health and Human Services, Office of Inspector General,
imposing mandatory exclusion under section 1320a-7(a). See Richard
Hauser, MD., 83 FR 26308 (2018).
Additionally, the Agency has consistently held that the underlying
conviction that led to mandatory exclusion does not need to involve
controlled substances to support a revocation or denial. See, e.g.,
Mohammed Asgar, MD., 83 FR 29569 (2018); Narciso A. Reyes, MD., 83 FR
61678 (2018); Richard Hauser, M.D., 83 FR at 26308; Orlando Ortega-
Ortiz, M.D., 70 FR 15122 (2005); Juan Pillot-Costas, MD., 69 FR 62804
(2004). However, evidence that the underlying conviction does not
relate to controlled substances can be used in mitigation. Mohammed
Asgar, MD., 83 FR at 29573 (noting respondent's conviction ``did not
involve the misuse of his registration to handle controlled
substances''); Kwan Bo Jin, M.D., 77 FR 35021, 35027 (2012) (showing a
lack of evidence concerning respondent's ``prescribing practices'').
The Agency must determine if a sanction is appropriate where the record
demonstrates ``questions as to the'' registrant's integrity. Anibal P.
Herrera, MD., 61 FR 65075, 65078 (1996).
Government's Burden of Proof and Establishment of a Prima Facie Case
Based upon my review of the allegations by the Government, it is
necessary to determine if it has met its prima facie burden of proving
the requirements for a sanction pursuant to 21 U.S.C. 824(a).
It is clear from the stipulations, the Government's evidence, and
the Respondent's position in this matter that there is no controversy
between the parties that the Respondent was convicted of the underlying
criminal charge in the U.S. District Court for the District of New
Jersey, and was subsequently mandatorily excluded from all federal
health care programs by HHS/OIG, pursuant to 42 U.S.C. 1320a-7(a). The
Government's evidence clearly demonstrates the necessary elements of
proof under 21 U.S.C. 824(a)(5) and I find that the Government has
established a prima facie case for revocation of the Respondent's COR
and denial of any pending applications.
Therefore, the remaining issue, and the central focus for
determination in this matter, is whether the Respondent has
sufficiently demonstrated that she has accepted responsibility for her
actions, has demonstrated remorse, and has taken sufficient
rehabilitative and remedial steps to demonstrate to the Acting
Administrator that she can be entrusted to maintain her COR. Kwan Bo
Jin, MD., 77 FR at 35021. The Agency must determine whether revocation
is the appropriate sanction ``to protect the public from individuals
who have misused controlled substances or their DEA Certificate of
Registration and who have not presented sufficient mitigating evidence
to assure the Administrative that they can be trusted with the
responsibility carried by such a registration.'' Jeffrey Stein, M.D.,
84 FR 46968, 46973 (2019) (quoting Leo R. Miller, MD., 53 FR 21931,
21932 (1988)). ``The Agency also looks to the nature of the crime in
determining the likelihood of recidivism and the need for deterrence.''
Id. In determining whether and to what extent a sanction is
appropriate, consideration must be given to both the egregiousness of
the offenses established by the Government's evidence and the Agency's
interest in both specific and general deterrence. David A. Ruben, M.D.,
78 FR 38363, 38364, 38385 (2013).\*C\
---------------------------------------------------------------------------
\*C\ Analysis of public interest factors omitted for relevance.
---------------------------------------------------------------------------
Acceptance of Responsibility and Rehabilitative Measures
The Government's prima facie burden having been met, [ ]\*D\ the
Respondent must present sufficient mitigating evidence to assure the
Administrator that she can be entrusted with the responsibility
incumbent with such registration. Medicine Shoppe, 73 FR at 387; Samuel
S. Jackson, 72 FR 23848, 23853 (2007). *[ ]The egregiousness and extent
of an applicant's misconduct are significant factors in determining the
appropriate sanction. See Jacobo Dreszer, 76 FR 19386, 19387-88 (2011)
(explaining that a respondent can ``argue that even though the
Government has made out a prima facie case, his conduct was not so
egregious as to warrant revocation''); Paul H. Vollanan, 73 FR 30630,
30644 (2008); Gregory D. Owens, 74 FR 36751, 36757 n.22 (2009).
---------------------------------------------------------------------------
\*D\ Omitted text for clarity and omitted text throughout this
section where noted with an asterisk to remove the public interest
analysis.
---------------------------------------------------------------------------
Since the exposure of the ``kick-back'' scheme, the Respondent has
maintained a consistent posture of acknowledging the impropriety and
illegality of her actions, of cooperation with the Government and of
truly commendable and extensive remedial efforts toward her goal of
``restorative justice.'' She has fully accepted responsibility for her
conduct, which led to the underlying criminal conviction, both in her
criminal prosecution, as well as in the instant proceeding. Tr. 83; FoF
33. The Respondent testified credibly during the hearing that ``I blame
myself only'' and that ``I was responsible for all of it.'' Tr. 57; FoF
24. When directly asked by Government counsel during cross-examination
if she accepted responsibility, she stated that she accepts ``one-
hundred percent'' responsibility for the acts that led to her criminal
conviction. Tr. 74, 83; FoF 32. The Respondent has further demonstrated
remorse for her crime. Tr. 75; FoF 35. She has repaid the bribes,
amended her tax returns, and paid the taxes on the money she took. Tr.
52; FoF 17. As for her speaking engagements, the Respondent has
completed sixty-nine speaking engagements, far beyond the required
thirty speaking engagements ordered by the District Court, and
continues to complete speaking engagements even though she is no longer
required to do so. Tr. 61-63, 66, 73; GX 2, p.2; FoF 26-29. She
completed all requirements for her probation on June 14, 2019. Tr. 89-
90; FoF 39. She has consistently demonstrated that she has taken the
necessary steps to rehabilitate herself and has demonstrated contrition
for her conduct that led to her underlying conviction.
During the underlying criminal proceedings, both the Assistant
United States Attorney (AUSA) and the sentencing U.S. District Court
Judge believed that the Respondent had accepted responsibility for her
conduct. The AUSA stated during the Respondent's sentencing hearing
that the Respondent ``had demonstrated a level of contrition that has
been unique among the many, many doctors that we've dealt with in this
case.'' Tr. 68-69; RX 9. Further, U.S. District Court Judge Stanley R.
Chesler found that the
[[Page 24020]]
Respondent had accepted responsibility. RX 9.\*E\
---------------------------------------------------------------------------
\*E\ Removed text. I agree with the Government that the District
Court's findings on acceptance of responsibility are not binding on
this agency, see Govt Posthearing Brief, at 9; however, I also agree
with the ALJ that these findings are relevant in that they further
support the ALJ's finding of Respondent's credible acceptance of
responsibility. See Mohammed Asgar, MD., 83 FR at 29573 n.3.
---------------------------------------------------------------------------
Although correcting improper behavior and practices is very
important to establish acceptance of responsibility, conceding
wrongdoing is critical to reestablishing trust with the Agency. Holiday
CVS, L.L.C., 77 FR 62316, 62346 (2012); Daniel A. Glick, D.D.S., 80 FR
at 74801. Based upon the evidence presented, I find that the Respondent
has demonstrated the full measure of acceptance of responsibility, and
has fully demonstrated that she is remorseful of her actions and has
taken considerable rehabilitative steps to ensure that this conduct
will not be repeated.
Loss of Trust
Where the Government has sustained its burden and established that
a registrant has committed acts inconsistent with the public interest,
that registrant must present sufficient mitigating evidence to assure
the Acting Administrator that he can be entrusted with the
responsibility commensurate with such a registration. Medicine Shoppe,
73 FR at 387.
As demonstrated by the evidence presented in this matter, it is
clear to me that the Respondent has unequivocally accepted
responsibility for her conduct. She continues to not only improve
herself, but works to ensure that current and future practitioners
learn from her past criminal conduct and will not make the same
choices. [I also find credible Respondent's statement that she would
``never do anything to compromise [her] license ever again.'' Tr. 122.]
Her underlying criminal conduct did not relate to her handling of
controlled substances and the Government has not alleged any
deficiencies by the Respondent related to controlled substances. The
Government argues that revocation in this matter is appropriate for its
deterrent effect. *[ ]*[Further, although I am not bound by them in
this case, I agree with the statements of] U.S. District Court Judge
Chesler found that ``in many ways your efforts may have as much, if not
more, impact than the prosecutions per se because it sends out a
message and it sends out a message from someone who has personally
impacted by having made the wrong decision.'' RX 9. It appears the
Respondent's outreach to physicians, medical staff and to students has
provided and continues to provide valuable deterrence to the medical
community. The Respondent's efforts have greatly satisfied the need for
deterrence. At sentencing, the AUSA stated that the Respondent's
``efforts have been substantial, including the speaking engagements
that she's been involved with. I can tell you, your Honor, that I have
heard unsolicited from folks in the medical field about the work that
she has been doing and folks who are involved in educating physicians
and supervising physicians have reported to me that her efforts have
made an impact in educating the community, which is meaningful thing
from the government's perspective.'' RX 9. *[In this case,] the
Respondent has clearly demonstrated that she can be entrusted to
properly maintain her COR.
Recommendation
Considering the entire record before me, the conduct of the
hearing, and observation of the testimony of the witnesses presented, I
find that the Government has met its burden of proof and has
established a prima facie case for revocation. However, *[ ] the
evidence overwhelmingly suggests that the Respondent has unequivocally
accepted responsibility, is remorseful for her conduct, has worked to
rehabilitate herself, has taken extraordinary steps to educate medical
personnel and students, and has presented convincing evidence
demonstrating that the Agency can entrust her to maintain her COR.
Therefore, I recommend the Respondent's DEA COR BM9434440 should Not be
Revoked and any pending applications for renewal or modification of
such registration, or for additional DEA registrations, be Granted
December 4, 2019
Mark M. Dowd,
U.S. Administrative Law Judge.
[FR Doc. 2021-09464 Filed 5-4-21; 8:45 am]
BILLING CODE 4410-09-P